BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Krammer F, Smith GJD, Fouchier RAM, Peiris M, Kedzierska K, Doherty PC, Palese P, Shaw ML, Treanor J, Webster RG, García-Sastre A. Influenza. Nat Rev Dis Primers 2018;4:3. [PMID: 29955068 DOI: 10.1038/s41572-018-0002-y] [Cited by in Crossref: 291] [Cited by in F6Publishing: 265] [Article Influence: 72.8] [Reference Citation Analysis]
Number Citing Articles
1 Buchy P, Badur S. Who and when to vaccinate against influenza. International Journal of Infectious Diseases 2020;93:375-87. [DOI: 10.1016/j.ijid.2020.02.040] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
2 Casanova JL, Abel L. Mechanisms of viral inflammation and disease in humans. Science 2021;374:1080-6. [PMID: 34822298 DOI: 10.1126/science.abj7965] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Rioux M, Francis ME, Swan CL, Ge A, Kroeker A, Kelvin AA. The Intersection of Age and Influenza Severity: Utility of Ferrets for Dissecting the Age-Dependent Immune Responses and Relevance to Age-Specific Vaccine Development. Viruses 2021;13:678. [PMID: 33920917 DOI: 10.3390/v13040678] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Alqazlan N, Astill J, Raj S, Sharif S. Strategies for enhancing immunity against avian influenza virus in chickens: A review. Avian Pathol 2022;:1-86. [PMID: 35297706 DOI: 10.1080/03079457.2022.2054309] [Reference Citation Analysis]
5 [DOI: 10.1101/2020.07.12.199687] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Boikos C, Imran M, Nguyen VH, Ducruet T, Sylvester GC, Mansi JA. Effectiveness of the Cell-Derived Inactivated Quadrivalent Influenza Vaccine in Individuals at High Risk of Influenza Complications in the 2018-2019 United States Influenza Season. Open Forum Infect Dis 2021;8:ofab167. [PMID: 34327253 DOI: 10.1093/ofid/ofab167] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Chen Z, Cui Q, Caffrey M, Rong L, Du R. Small Molecule Inhibitors of Influenza Virus Entry. Pharmaceuticals (Basel) 2021;14:587. [PMID: 34207368 DOI: 10.3390/ph14060587] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Tao YY, Li JX, Hu YM, Hu YS, Zeng G, Zhu FC. Quadrivalent influenza vaccine (Sinovac Biotech) for seasonal influenza prophylaxis. Expert Rev Vaccines 2021;20:1-11. [PMID: 33434084 DOI: 10.1080/14760584.2021.1875823] [Reference Citation Analysis]
9 Duong BT, Bal J, Sung HW, Yeo SJ, Park H. Molecular Analysis of the Avian H7 Influenza Viruses Circulating in South Korea during 2018-2019: Evolutionary Significance and Associated Zoonotic Threats. Viruses 2021;13:2260. [PMID: 34835066 DOI: 10.3390/v13112260] [Reference Citation Analysis]
10 Nickol ME, Kindrachuk J. A year of terror and a century of reflection: perspectives on the great influenza pandemic of 1918-1919. BMC Infect Dis 2019;19:117. [PMID: 30727970 DOI: 10.1186/s12879-019-3750-8] [Cited by in Crossref: 43] [Cited by in F6Publishing: 25] [Article Influence: 14.3] [Reference Citation Analysis]
11 Zhao H, Jiang S, Ye Z, Zhu H, Hu B, Meng P, Hu Y, Zhang H, Wang K, Wang J, Tian Y. Discovery of hydrazide-containing oseltamivir analogues as potent inhibitors of influenza A neuraminidase. Eur J Med Chem 2021;221:113567. [PMID: 34082224 DOI: 10.1016/j.ejmech.2021.113567] [Reference Citation Analysis]
12 Du X, Wu G, Zhu Y, Zhang S. Exploring the epidemiological changes of common respiratory viruses since the COVID-19 pandemic: a hospital study in Hangzhou, China. Arch Virol 2021;166:3085-92. [PMID: 34480636 DOI: 10.1007/s00705-021-05214-8] [Reference Citation Analysis]
13 Li Q, Bai C, Yang R, Xing W, Pang X, Wu S, Liu S, Chen J, Liu T, Gu X. Deciphering the Pharmacological Mechanisms of Ma Xing Shi Gan Decoction against COVID-19 through Integrating Network Pharmacology and Experimental Exploration. Front Pharmacol 2020;11:581691. [PMID: 33324213 DOI: 10.3389/fphar.2020.581691] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
14 Kellermann M, Scharte F, Hensel M. Manipulation of Host Cell Organelles by Intracellular Pathogens. Int J Mol Sci 2021;22:6484. [PMID: 34204285 DOI: 10.3390/ijms22126484] [Reference Citation Analysis]
15 Nagashima KA, Mousa JJ. Next-Generation Influenza HA Immunogens and Adjuvants in Pursuit of a Broadly Protective Vaccine. Viruses 2021;13:546. [PMID: 33805245 DOI: 10.3390/v13040546] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 McKellar J, Rebendenne A, Wencker M, Moncorgé O, Goujon C. Mammalian and Avian Host Cell Influenza A Restriction Factors. Viruses 2021;13:522. [PMID: 33810083 DOI: 10.3390/v13030522] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Dhakal S, Klein SL. Host Factors Impact Vaccine Efficacy: Implications for Seasonal and Universal Influenza Vaccine Programs. J Virol 2019;93:e00797-19. [PMID: 31391269 DOI: 10.1128/JVI.00797-19] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 10.7] [Reference Citation Analysis]
18 Jung HE, Lee HK. Host Protective Immune Responses against Influenza A Virus Infection. Viruses 2020;12:E504. [PMID: 32375274 DOI: 10.3390/v12050504] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
19 Peter S, Hölzer M, Lamkiewicz K, di Fenizio PS, Al Hwaeer H, Marz M, Schuster S, Dittrich P, Ibrahim B. Structure and Hierarchy of Influenza Virus Models Revealed by Reaction Network Analysis. Viruses 2019;11:E449. [PMID: 31100972 DOI: 10.3390/v11050449] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
20 Segrelles-Calvo G, de S Araújo GR, Frases S. Systemic mycoses: a potential alert for complications in COVID-19 patients. Future Microbiol 2020;15:1405-13. [PMID: 33085538 DOI: 10.2217/fmb-2020-0156] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
21 Scantling-Birch Y, Newton R, Naveed H, Rajak S, Bhutta MF. Healthcare worker protection against epidemic viral respiratory disease. Postgrad Med J 2021:postgradmedj-2020-139555. [PMID: 33637641 DOI: 10.1136/postgradmedj-2020-139555] [Reference Citation Analysis]
22 Grant EJ, Josephs TM, Loh L, Clemens EB, Sant S, Bharadwaj M, Chen W, Rossjohn J, Gras S, Kedzierska K. Broad CD8+ T cell cross-recognition of distinct influenza A strains in humans. Nat Commun 2018;9:5427. [PMID: 30575715 DOI: 10.1038/s41467-018-07815-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
23 Chen KY, Santos Afonso ED, Enouf V, Isel C, Naffakh N. Influenza virus polymerase subunits co-evolve to ensure proper levels of dimerization of the heterotrimer. PLoS Pathog 2019;15:e1008034. [PMID: 31581279 DOI: 10.1371/journal.ppat.1008034] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
24 Zhang J, Huang X, Ding D, Tao Z. Platelet-driven coagulopathy in COVID-19 patients: in comparison to seasonal influenza cases. Exp Hematol Oncol 2021;10:34. [PMID: 34059141 DOI: 10.1186/s40164-021-00228-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5:536-544. [PMID: 32123347 DOI: 10.1038/s41564-020-0695-z] [Cited by in Crossref: 2735] [Cited by in F6Publishing: 2291] [Article Influence: 1367.5] [Reference Citation Analysis]
26 Jung J, Mundle ST, Ustyugova IV, Horton AP, Boutz DR, Pougatcheva S, Prabakaran P, McDaniel JR, King GR, Park D, Person MD, Ye C, Tan B, Tanno Y, Kim JE, Curtis NC, DiNapoli J, Delagrave S, Ross TM, Ippolito GC, Kleanthous H, Lee J, Georgiou G. Influenza vaccination in the elderly boosts antibodies against conserved viral proteins and egg-produced glycans. J Clin Invest 2021;131:148763. [PMID: 34196304 DOI: 10.1172/JCI148763] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Keshavarz M, Sabbaghi A, Koushki K, Miri SM, Sarshari B, Vahdat K, Ghaemi A. Epigenetic reprogramming mechanisms of immunity during influenza A virus infection. Microbes Infect 2021;:104831. [PMID: 33878459 DOI: 10.1016/j.micinf.2021.104831] [Reference Citation Analysis]
28 Chua SCJH, Tan HQ, Engelberg D, Lim LHK. Alternative Experimental Models for Studying Influenza Proteins, Host-Virus Interactions and Anti-Influenza Drugs. Pharmaceuticals (Basel) 2019;12:E147. [PMID: 31575020 DOI: 10.3390/ph12040147] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
29 Jasinski-bergner S, Schmiedel D, Mandelboim O, Seliger B. Role of HLA-G in Viral Infections. Front Immunol 2022;13:826074. [DOI: 10.3389/fimmu.2022.826074] [Reference Citation Analysis]
30 Ma N, Li X, Jiang H, Dai Y, Xu G, Zhang Z. Influenza Virus Neuraminidase Engages CD83 and Promotes Pulmonary Injury. J Virol 2021;95:e01753-20. [PMID: 33177200 DOI: 10.1128/JVI.01753-20] [Reference Citation Analysis]
31 Tanner AR, Dorey RB, Brendish NJ, Clark TW. Influenza vaccination: protecting the most vulnerable. Eur Respir Rev 2021;30:200258. [PMID: 33650528 DOI: 10.1183/16000617.0258-2020] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Rahil Z, Leylek R, Schürch CM, Chen H, Bjornson-Hooper Z, Christensen SR, Gherardini PF, Bhate SS, Spitzer MH, Fragiadakis GK, Mukherjee N, Kim N, Jiang S, Yo J, Gaudilliere B, Affrime M, Bock B, Hensley SE, Idoyaga J, Aghaeepour N, Kim K, Nolan GP, McIlwain DR. Landscape of coordinated immune responses to H1N1 challenge in humans. J Clin Invest 2020;130:5800-16. [PMID: 33044226 DOI: 10.1172/JCI137265] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
33 Russell CJ. Hemagglutinin Stability and Its Impact on Influenza A Virus Infectivity, Pathogenicity, and Transmissibility in Avians, Mice, Swine, Seals, Ferrets, and Humans. Viruses 2021;13:746. [PMID: 33923198 DOI: 10.3390/v13050746] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
34 Hussain A, Yang H, Zhang M, Liu Q, Alotaibi G, Irfan M, He H, Chang J, Liang XJ, Weng Y, Huang Y. mRNA vaccines for COVID-19 and diverse diseases. J Control Release 2022;345:314-33. [PMID: 35331783 DOI: 10.1016/j.jconrel.2022.03.032] [Reference Citation Analysis]
35 Jiang C, Yao X, Zhao Y, Wu J, Huang P, Pan C, Liu S, Pan C. Comparative review of respiratory diseases caused by coronaviruses and influenza A viruses during epidemic season. Microbes Infect. 2020;22:236-244. [PMID: 32405236 DOI: 10.1016/j.micinf.2020.05.005] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 15.0] [Reference Citation Analysis]
36 Chang N, Zhang C, Mei X, Du F, Li J, Zhang L, Du H, Yun F, Aji D, Shi W, Bi Y, Ma Z. Novel reassortment 2.3.4.4b H5N8 highly pathogenic avian influenza viruses circulating in Xinjiang, China. Prev Vet Med 2021;199:105564. [PMID: 34959041 DOI: 10.1016/j.prevetmed.2021.105564] [Reference Citation Analysis]
37 Carlson CJ, Gibb RJ, Albery GF, Brierley L, Connor RP, Dallas TA, Eskew EA, Fagre AC, Farrell MJ, Frank HK, Muylaert RL, Poisot T, Rasmussen AL, Ryan SJ, Seifert SN. The Global Virome in One Network (VIRION): an Atlas of Vertebrate-Virus Associations. mBio 2022;:e0298521. [PMID: 35229639 DOI: 10.1128/mbio.02985-21] [Reference Citation Analysis]
38 Tang Y, Yang G, Li Y, Wang M, Li G, Hu Y. Protective effects of SP600125 on mice infected with H1N1 influenza A virus. Arch Virol 2021;166:2151-8. [PMID: 34014386 DOI: 10.1007/s00705-021-05103-0] [Reference Citation Analysis]
39 Lee I, Kim SE, Lee J, Woo DH, Lee S, Pyo H, Song CS, Lee J. A self-calibrating electrochemical aptasensing platform: Correcting external interference errors for the reliable and stable detection of avian influenza viruses. Biosens Bioelectron 2020;152:112010. [PMID: 31941618 DOI: 10.1016/j.bios.2020.112010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
40 Koutsakos M, Illing PT, Nguyen THO, Mifsud NA, Crawford JC, Rizzetto S, Eltahla AA, Clemens EB, Sant S, Chua BY, Wong CY, Allen EK, Teng D, Dash P, Boyd DF, Grzelak L, Zeng W, Hurt AC, Barr I, Rockman S, Jackson DC, Kotsimbos TC, Cheng AC, Richards M, Westall GP, Loudovaris T, Mannering SI, Elliott M, Tangye SG, Wakim LM, Rossjohn J, Vijaykrishna D, Luciani F, Thomas PG, Gras S, Purcell AW, Kedzierska K. Human CD8+ T cell cross-reactivity across influenza A, B and C viruses. Nat Immunol 2019;20:613-25. [PMID: 30778243 DOI: 10.1038/s41590-019-0320-6] [Cited by in Crossref: 93] [Cited by in F6Publishing: 81] [Article Influence: 31.0] [Reference Citation Analysis]
41 Jiang D, Tian Y, Zhang Y, Lu X, Xiao D, Zhou C. One-step fast and label-free imaging array for multiplexed detection of trace avian influenza viruses. Anal Chim Acta 2021;1171:338645. [PMID: 34112438 DOI: 10.1016/j.aca.2021.338645] [Reference Citation Analysis]
42 Du W, de Vries E, van Kuppeveld FJM, Matrosovich M, de Haan CAM. Second sialic acid-binding site of influenza A virus neuraminidase: binding receptors for efficient release. FEBS J 2020. [PMID: 33314755 DOI: 10.1111/febs.15668] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
43 Zarei Ghobadi M, Mozhgani SH, Farzanehpour M, Behzadian F. Identifying novel biomarkers of the pediatric influenza infection by weighted co-expression network analysis. Virol J 2019;16:124. [PMID: 31665046 DOI: 10.1186/s12985-019-1231-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
44 Douillet C, Moloney M, Di Rocco M, Elliott C, Danaher M. Development and validation of a quantitative method for 15 antiviral drugs in poultry muscle using liquid chromatography coupled to tandem mass spectrometry. J Chromatogr A 2021;1665:462793. [PMID: 35030475 DOI: 10.1016/j.chroma.2021.462793] [Reference Citation Analysis]
45 Stervbo U, Rahmann S, Roch T, Westhoff TH, Babel N. Epitope similarity cannot explain the pre-formed T cell immunity towards structural SARS-CoV-2 proteins. Sci Rep 2020;10:18995. [PMID: 33149224 DOI: 10.1038/s41598-020-75972-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
46 Lee JH, Oh SJ, Yun J, Shin OS. Nonstructural Protein NS1 of Influenza Virus Disrupts Mitochondrial Dynamics and Enhances Mitophagy via ULK1 and BNIP3. Viruses 2021;13:1845. [PMID: 34578425 DOI: 10.3390/v13091845] [Reference Citation Analysis]
47 Nüssing S, Mifsud E, Hensen L, Koutsakos M, Wang Z, Kedzierski L, Mercuri F, Rossignol JF, Hurt AC, Kedzierska K. Viral burden, inflammatory milieu and CD8+ T-cell responses to influenza virus in a second-generation thiazolide (RM-5061) and oseltamivir combination therapy study. Influenza Other Respir Viruses 2020;14:678-87. [PMID: 32588557 DOI: 10.1111/irv.12776] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
48 Del Rosario JMM, da Costa KAS, Asbach B, Ferrara F, Ferrari M, Wells DA, Mann GS, Ameh VO, Sabeta CT, Banyard AC, Kinsley R, Scott SD, Wagner R, Heeney JL, Carnell GW, Temperton NJ. Exploiting Pan Influenza A and Pan Influenza B Pseudotype Libraries for Efficient Vaccine Antigen Selection. Vaccines (Basel) 2021;9:741. [PMID: 34358157 DOI: 10.3390/vaccines9070741] [Reference Citation Analysis]
49 Ilyina IV, Patrusheva OS, Zarubaev VV, Misiurina MA, Slita AV, Esaulkova IL, Korchagina DV, Gatilov YV, Borisevich SS, Volcho KP, Salakhutdinov NF. Influenza antiviral activity of F- and OH-containing isopulegol-derived octahydro-2H-chromenes. Bioorg Med Chem Lett 2021;31:127677. [PMID: 33171219 DOI: 10.1016/j.bmcl.2020.127677] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
50 Sánchez-de Prada L, Rojo-Rello S, Domínguez-Gil M, Tamayo-Gómez E, Ortiz de Lejarazu-Leonardo R, Eiros JM, Sanz-Muñoz I. Influenza B Lineages Have More in Common Than Meets the Eye. Trivalent Influenza Vaccines Trigger Heterotypic Antibodies Against Both Influenza B Viruses. Front Microbiol 2021;12:737216. [PMID: 34858361 DOI: 10.3389/fmicb.2021.737216] [Reference Citation Analysis]
51 [DOI: 10.1101/2020.04.03.014282] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
52 Kim KH, Jung YJ, Lee Y, Park BR, Oh J, Lee YN, Kim MC, Jeeva S, Kang SM. Cross protection by inactivated recombinant influenza viruses containing chimeric hemagglutinin conjugates with a conserved neuraminidase or M2 ectodomain epitope. Virology 2020;550:51-60. [PMID: 32882637 DOI: 10.1016/j.virol.2020.08.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 Reis R, Adragão F, Parente C, Nunes I, Ramos A, Nabais I, Silva I. A Seasonal Cause of Encephalitis: Influenza Virus A (H3N1) Infection. Eur J Case Rep Intern Med 2021;8:002336. [PMID: 33768079 DOI: 10.12890/2021_002336] [Reference Citation Analysis]
54 Kim M, Choi H, Kim S, Kang LW, Kim YB. Elucidating the Effects of Curcumin against Influenza Using In Silico and In Vitro Approaches. Pharmaceuticals (Basel) 2021;14:880. [PMID: 34577580 DOI: 10.3390/ph14090880] [Reference Citation Analysis]
55 Pabbaraju K, Wong AA, Ma R, Zelyas N, Tipples GA. Development and validation of a multiplex reverse transcriptase-PCR assay for simultaneous testing of influenza A, influenza B and SARS-CoV-2. J Virol Methods 2021;293:114151. [PMID: 33839186 DOI: 10.1016/j.jviromet.2021.114151] [Reference Citation Analysis]
56 Vanderlinden E, Van Winkel N, Naesens L, Van Damme EJM, Persoons L, Schols D. In Vitro Characterization of the Carbohydrate-Binding Agents HHA, GNA, and UDA as Inhibitors of Influenza A and B Virus Replication. Antimicrob Agents Chemother 2021;65:e01732-20. [PMID: 33288640 DOI: 10.1128/AAC.01732-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Sato-Kaneko F, Yao S, Lao FS, Shpigelman J, Messer K, Pu M, Shukla NM, Cottam HB, Chan M, Chu PJ, Burkhart D, Schoener R, Matsutani T, Carson DA, Corr M, Hayashi T. A Novel Synthetic Dual Agonistic Liposomal TLR4/7 Adjuvant Promotes Broad Immune Responses in an Influenza Vaccine With Minimal Reactogenicity. Front Immunol 2020;11:1207. [PMID: 32636840 DOI: 10.3389/fimmu.2020.01207] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
58 Dhakal S, Klein SL. Host Factors Impact Vaccine Efficacy: Implications for Seasonal and Universal Influenza Vaccine Programs. J Virol 2019;93:e00797-19. [PMID: 31391269 DOI: 10.1128/JVI.00797-19] [Cited by in Crossref: 47] [Article Influence: 15.7] [Reference Citation Analysis]
59 Kincses A, Santa-Maria AR, Walter FR, Dér L, Horányi N, Lipka DV, Valkai S, Deli MA, Dér A. A chip device to determine surface charge properties of confluent cell monolayers by measuring streaming potential. Lab Chip 2020;20:3792-805. [PMID: 32914817 DOI: 10.1039/d0lc00558d] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
60 Dou W, Qin Z, Li J, Zhou D, He X. Self-assembled sialyllactosyl probes with aggregation-enhanced properties for ratiometric detection and blocking of influenza viruses. Science Bulletin 2019;64:1902-9. [DOI: 10.1016/j.scib.2019.08.020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
61 Hansen KP, Benn CS, Aamand T, Buus M, da Silva I, Aaby P, Fisker AB, Thysen SM. Does Influenza Vaccination during Pregnancy Have Effects on Non-Influenza Infectious Morbidity? A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Vaccines (Basel) 2021;9:1452. [PMID: 34960198 DOI: 10.3390/vaccines9121452] [Reference Citation Analysis]
62 Samel-Kowalik P, Jankowski M, Lisiecka-Biełanowicz M, Ostrowska A, Gujski M, Kobuszewski B, Pinkas J, Raciborski F. Factors Associated with Attitudes towards Seasonal Influenza Vaccination in Poland: A Nationwide Cross-Sectional Survey in 2020. Vaccines (Basel) 2021;9:1336. [PMID: 34835267 DOI: 10.3390/vaccines9111336] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Häfner SJ. Evergreen influenza - Tackling an old enemy with fresh munitions. Biomed J 2019;42:1-4. [PMID: 30987700 DOI: 10.1016/j.bj.2019.02.005] [Reference Citation Analysis]
64 Declercq M, Biquand E, Karim M, Pietrosemoli N, Jacob Y, Demeret C, Barbezange C, van der Werf S. Influenza A virus co-opts ERI1 exonuclease bound to histone mRNA to promote viral transcription. Nucleic Acids Res 2020;48:10428-40. [PMID: 32960265 DOI: 10.1093/nar/gkaa771] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Cheng WL, Lin CS. Transient Atrioventricular Block as a Complication of Influenza A Virus: A Case Report. J Acute Med 2021;11:102-4. [PMID: 34595094 DOI: 10.6705/j.jacme.202109_11(3).0004] [Reference Citation Analysis]
66 Zhang C, Cui H, Zhang C, Chen Z, Jiang X, Liu J, Wan Z, Li J, Liu J, Gao Y, Jin N, Guo Z. Aerosol Transmission of the Pandemic SARS-CoV-2 and Influenza A Virus Was Blocked by Negative Ions. Front Cell Infect Microbiol 2022;12:897416. [DOI: 10.3389/fcimb.2022.897416] [Reference Citation Analysis]
67 Fodor E, Te Velthuis AJW. Structure and Function of the Influenza Virus Transcription and Replication Machinery. Cold Spring Harb Perspect Med 2020;10:a038398. [PMID: 31871230 DOI: 10.1101/cshperspect.a038398] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
68 Sączyńska V, Florys-Jankowska K, Porębska A, Cecuda-Adamczewska V. A novel epitope-blocking ELISA for specific and sensitive detection of antibodies against H5-subtype influenza virus hemagglutinin. Virol J 2021;18:91. [PMID: 33931074 DOI: 10.1186/s12985-021-01564-6] [Reference Citation Analysis]
69 Kiseleva I, Ksenafontov A. COVID-19 Shuts Doors to Flu but Keeps Them Open to Rhinoviruses. Biology (Basel) 2021;10:733. [PMID: 34439965 DOI: 10.3390/biology10080733] [Reference Citation Analysis]
70 Huang QJ, Song K, Xu C, Bolon DN, Wang JP, Finberg RW, Schiffer CA, Somasundaran M. Quantitative structural analysis of influenza virus by cryo-electron tomography and convolutional neural networks. Structure 2022. [DOI: 10.1016/j.str.2022.02.014] [Reference Citation Analysis]
71 Huang Q, Song W, Liang F, Ye B, Li Z, Zhang X, Zhong W, Zhang P, Liu D, Shen D, Chen P, Liu Q, Yang X, Mao C. Non-Pharmaceutical Interventions Implemented to Control the COVID-19 Were Associated With Reduction of Influenza Incidence. Front Public Health 2022;10:773271. [DOI: 10.3389/fpubh.2022.773271] [Reference Citation Analysis]
72 Komadina N, Sullivan SG, Leder K, McVernon J. Likelihood of prior exposure to circulating influenza viruses resulting in cross-protection by CD8+ T cells against emergent H3N2v swine viruses infecting humans. J Med Virol 2021. [PMID: 34449904 DOI: 10.1002/jmv.27299] [Reference Citation Analysis]
73 Park G, Kim HO, Lim JW, Park C, Yeom M, Song D, Haam S. Rapid detection of influenza A (H1N1) virus by conductive polymer-based nanoparticle via optical response to virus-specific binding. Nano Res 2021;:1-9. [PMID: 34567436 DOI: 10.1007/s12274-021-3772-6] [Reference Citation Analysis]
74 Cáceres CJ, Rajao DS, Perez DR. Airborne Transmission of Avian Origin H9N2 Influenza A Viruses in Mammals. Viruses 2021;13:1919. [PMID: 34696349 DOI: 10.3390/v13101919] [Reference Citation Analysis]
75 Rioux M, McNeil M, Francis ME, Dawe N, Foley M, Langley JM, Kelvin AA. The Power of First Impressions: Can Influenza Imprinting during Infancy Inform Vaccine Design? Vaccines (Basel) 2020;8:E546. [PMID: 32961707 DOI: 10.3390/vaccines8030546] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
76 Duan C, Liu W, Bi S, Chen L, Pan J, Zhou T, Lin K, Zhou W. Synthesis and characterization of 4( R )‐epimer impurities of zanamivir and laninamivir octanoate. J Heterocyclic Chem. [DOI: 10.1002/jhet.4402] [Reference Citation Analysis]
77 Sotoudeh H, Tabatabaei M, Tasorian B, Tavakol K, Sotoudeh E, Moini AL. Artificial Intelligence Empowers Radiologists to Differentiate Pneumonia Induced by COVID-19 versus Influenza Viruses. Acta Inform Med 2020;28:190-5. [PMID: 33417642 DOI: 10.5455/aim.2020.28.190-195] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Trombetta CM, Marchi S, Manini I, Lazzeri G, Montomoli E. Challenges in the development of egg-independent vaccines for influenza. Expert Review of Vaccines 2019;18:737-50. [DOI: 10.1080/14760584.2019.1639503] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
79 Carreño JM, Strohmeier S, Kirkpatrick Roubidoux E, Hai R, Palese P, Krammer F. H1 Hemagglutinin Priming Provides Long-Lasting Heterosubtypic Immunity against H5N1 Challenge in the Mouse Model. mBio 2020;11:e02090-20. [PMID: 33323511 DOI: 10.1128/mBio.02090-20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
80 Nilsson-Payant BE, Blanco-Melo D, Uhl S, Escudero-Pérez B, Olschewski S, Thibault P, Panis M, Rosenthal M, Muñoz-Fontela C, Lee B, tenOever BR. Reduced Nucleoprotein Availability Impairs Negative-Sense RNA Virus Replication and Promotes Host Recognition. J Virol 2021;95:e02274-20. [PMID: 33568513 DOI: 10.1128/JVI.02274-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
81 Santos P, Almeida F. Exosome-Based Vaccines: History, Current State, and Clinical Trials. Front Immunol 2021;12:711565. [PMID: 34335627 DOI: 10.3389/fimmu.2021.711565] [Reference Citation Analysis]
82 Malausse N, van der Werf S, Naffakh N, Munier S. Influenza B Virus Infection Is Enhanced Upon Heterotypic Co-infection With Influenza A Virus. Front Microbiol 2021;12:631346. [PMID: 33717023 DOI: 10.3389/fmicb.2021.631346] [Reference Citation Analysis]
83 Apaydın ÇB, Tansuyu M, Cesur Z, Naesens L, Göktaş F. Design, synthesis and anti-influenza virus activity of furan-substituted spirothiazolidinones. Bioorg Chem 2021;112:104958. [PMID: 33979734 DOI: 10.1016/j.bioorg.2021.104958] [Reference Citation Analysis]
84 Lipničanová S, Legerská B, Chmelová D, Ondrejovič M, Miertuš S. Optimization of an Inclusion Body-Based Production of the Influenza Virus Neuraminidase in Escherichia coli. Biomolecules 2022;12:331. [PMID: 35204831 DOI: 10.3390/biom12020331] [Reference Citation Analysis]
85 Nguyen THO, Koutsakos M, van de Sandt CE, Crawford JC, Loh L, Sant S, Grzelak L, Allen EK, Brahm T, Clemens EB, Auladell M, Hensen L, Wang Z, Nüssing S, Jia X, Günther P, Wheatley AK, Kent SJ, Aban M, Deng YM, Laurie KL, Hurt AC, Gras S, Rossjohn J, Crowe J, Xu J, Jackson D, Brown LE, La Gruta N, Chen W, Doherty PC, Turner SJ, Kotsimbos TC, Thomas PG, Cheng AC, Kedzierska K. Immune cellular networks underlying recovery from influenza virus infection in acute hospitalized patients. Nat Commun 2021;12:2691. [PMID: 33976217 DOI: 10.1038/s41467-021-23018-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
86 Belser JA, Pulit-Penaloza JA, Maines TR. Ferreting Out Influenza Virus Pathogenicity and Transmissibility: Past and Future Risk Assessments in the Ferret Model. Cold Spring Harb Perspect Med 2020;10:a038323. [PMID: 31871233 DOI: 10.1101/cshperspect.a038323] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
87 Gao S, Zhang W, Lu C, Cao M, Cen S, Peng Y, Deng T. Identification of a Type-Specific Promoter Element That Differentiates between Influenza A and B Viruses. J Virol 2019;93:e01164-19. [PMID: 31534045 DOI: 10.1128/JVI.01164-19] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
88 Cheng C, Li J, Liu W, Xu L, Zhang Z. Modeling analysis revealed the distinct global transmission patterns of influenza A viruses and their influencing factors. Integr Zool 2021;16:788-97. [PMID: 32649020 DOI: 10.1111/1749-4877.12469] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
89 Yim HCH, Leon TYY, Li JCB. MXD1 regulates the H9N2 and H1N1 influenza A virus-induced chemokine expression and their replications in human macrophage. J Leukoc Biol 2020;108:1631-40. [PMID: 32794336 DOI: 10.1002/JLB.4MA0620-703RR] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
90 More AF, Loveluck CP, Clifford H, Handley MJ, Korotkikh EV, Kurbatov AV, McCormick M, Mayewski PA. The Impact of a Six-Year Climate Anomaly on the "Spanish Flu" Pandemic and WWI. Geohealth 2020;4:e2020GH000277. [PMID: 33005839 DOI: 10.1029/2020GH000277] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
91 Zhou L, Li J, Shi D, Xu L, Huang SX. Predicting Influenza Epidemic for United States. Int J Environ Health Res 2020;:1-7. [PMID: 33378220 DOI: 10.1080/09603123.2020.1866754] [Reference Citation Analysis]
92 Jabeen M, Dutot M, Fagon R, Verrier B, Monge C. Seaweed Sulfated Polysaccharides against Respiratory Viral Infections. Pharmaceutics 2021;13:733. [PMID: 34065660 DOI: 10.3390/pharmaceutics13050733] [Reference Citation Analysis]
93 Detzner J, Steil D, Pohlentz G, Legros N, Müthing J. Surface acoustic wave (SAW) real-time interaction analysis of influenza A virus hemagglutinins with sialylated neoglycolipids. Glycobiology 2021:cwab009. [PMID: 33527987 DOI: 10.1093/glycob/cwab009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
94 Cohen AA, Yang Z, Gnanapragasam PNP, Ou S, Dam KA, Wang H, Bjorkman PJ. Construction, characterization, and immunization of nanoparticles that display a diverse array of influenza HA trimers. PLoS One 2021;16:e0247963. [PMID: 33661993 DOI: 10.1371/journal.pone.0247963] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
95 Škubník J, Bejček J, Pavlíčková VS, Rimpelová S. Repurposing Cardiac Glycosides: Drugs for Heart Failure Surmounting Viruses. Molecules 2021;26:5627. [PMID: 34577097 DOI: 10.3390/molecules26185627] [Reference Citation Analysis]
96 Wei J, Huang H, Qin H, Li S, Xing L, Li Y, Cao M, Wang Y, Bi Y, Liu Y, Yang Y. A newly developed real-time PCR assay for discriminating influenza B virus Yamagata and Victoria lineages. J Med Virol 2020. [PMID: 32497291 DOI: 10.1002/jmv.26133] [Reference Citation Analysis]
97 Trexler M, Brusatori M, Auner G. Avidin-biotin complex-based capture coating platform for universal Influenza virus immobilization and characterization. PLoS One 2021;16:e0247429. [PMID: 33635877 DOI: 10.1371/journal.pone.0247429] [Reference Citation Analysis]
98 Rodriguez-Frandsen A, Martin-Sancho L, Gounder AP, Chang MW, Liu WC, De Jesus PD, von Recum-Knepper J, Dutra MS, Huffmaster NJ, Chavarria M, Mena I, Riva L, Nguyen CB, Dobariya S, Herbert KM, Benner C, Albrecht RA, García-Sastre A, Chanda SK. Viral Determinants in H5N1 Influenza A Virus Enable Productive Infection of HeLa Cells. J Virol 2020;94:e01410-19. [PMID: 31776276 DOI: 10.1128/JVI.01410-19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
99 Chistov AA, Orlov AA, Streshnev PP, Slesarchuk NA, Aparin IO, Rathi B, Brylev VA, Kutyakov SV, Mikhura IV, Ustinov AV, Westman G, Palyulin VA, Jain N, Osolodkin DI, Kozlovskaya LI, Korshun VA. Compounds based on 5-(perylen-3-ylethynyl)uracil scaffold: High activity against tick-borne encephalitis virus and non-specific activity against enterovirus A. Eur J Med Chem 2019;171:93-103. [PMID: 30909022 DOI: 10.1016/j.ejmech.2019.03.029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
100 Jones WA, Castro RC, Masters HL 3rd, Carrico R. Influenza Management During the COVID-19 Pandemic: A Review of Recent Innovations in Antiviral Therapy and Relevance to Primary Care Practice. Mayo Clin Proc Innov Qual Outcomes 2021;5:974-91. [PMID: 34414356 DOI: 10.1016/j.mayocpiqo.2021.07.005] [Reference Citation Analysis]
101 de Hoog MLA, Venekamp RP, Meijer A, Sanders EAM, Bruijning-Verhagen PCJL. Inactivated influenza vaccine does not reduce all cause respiratory illness in children with pre-existing medical conditions. Vaccine 2020;38:3397-403. [PMID: 31859200 DOI: 10.1016/j.vaccine.2019.11.086] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
102 Rockman S, Laurie KL, Parkes S, Wheatley A, Barr IG. New Technologies for Influenza Vaccines. Microorganisms 2020;8:E1745. [PMID: 33172191 DOI: 10.3390/microorganisms8111745] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
103 Ainsua-Enrich E, Hatipoglu I, Kadel S, Turner S, Paul J, Singh S, Bagavant H, Kovats S. IRF4-dependent dendritic cells regulate CD8+ T-cell differentiation and memory responses in influenza infection. Mucosal Immunol 2019;12:1025-37. [PMID: 31089186 DOI: 10.1038/s41385-019-0173-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
104 Eni-Aganga I, Lanaghan ZM, Balasubramaniam M, Dash C, Pandhare J. PROLIDASE: A Review from Discovery to its Role in Health and Disease. Front Mol Biosci 2021;8:723003. [PMID: 34532344 DOI: 10.3389/fmolb.2021.723003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
105 Kesavardhana S, Samir P, Zheng M, Malireddi RKS, Karki R, Sharma BR, Place DE, Briard B, Vogel P, Kanneganti TD. DDX3X coordinates host defense against influenza virus by activating the NLRP3 inflammasome and type I interferon response. J Biol Chem 2021;296:100579. [PMID: 33766561 DOI: 10.1016/j.jbc.2021.100579] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
106 Abbott TR, Dhamdhere G, Liu Y, Lin X, Goudy L, Zeng L, Chemparathy A, Chmura S, Heaton NS, Debs R, Pande T, Endy D, La Russa MF, Lewis DB, Qi LS. Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza. Cell 2020;181:865-876.e12. [PMID: 32353252 DOI: 10.1016/j.cell.2020.04.020] [Cited by in Crossref: 130] [Cited by in F6Publishing: 123] [Article Influence: 65.0] [Reference Citation Analysis]
107 Yi C, Yi Y, Li J, Sacitharan PK. Protecting against different subtypes of influenza viruses: a nanoparticle approach. Signal Transduct Target Ther 2020;5:50. [PMID: 32327631 DOI: 10.1038/s41392-020-0157-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
108 Mittal N, Sengupta N, Malladi SK, Reddy P, Bhat M, Rajmani RS, Sedeyn K, Saelens X, Dutta S, Varadarajan R. Protective Efficacy of Recombinant Influenza Hemagglutinin Ectodomain Fusions. Viruses 2021;13:1710. [PMID: 34578291 DOI: 10.3390/v13091710] [Reference Citation Analysis]
109 de Hoog MLA, Venekamp RP, Damoiseaux RAMJ, Schilder AGM, Sanders EAM, Smit HA, Bruijning-Verhagen PCJL. Impact of Repeated Influenza Immunization on Respiratory Illness in Children With Preexisting Medical Conditions. Ann Fam Med 2019;17:7-13. [PMID: 30670389 DOI: 10.1370/afm.2340] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
110 Zhang H, Wang K, Zhu H, Zhao X, Zhao H, Lei Z, Chen B, Yang F, Liu K, Zhang K, Wang J, Tian Y. Discovery of a non-zwitterionic oseltamivir analogue as a potent influenza a neuraminidase inhibitor. European Journal of Medicinal Chemistry 2020;200:112423. [DOI: 10.1016/j.ejmech.2020.112423] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
111 Bisset AT, Hoyne GF. An Outbreak of Highly Pathogenic Avian Influenza (H7N7) in Australia and the Potential for Novel Influenza A Viruses to Emerge. Microorganisms 2021;9:1639. [PMID: 34442718 DOI: 10.3390/microorganisms9081639] [Reference Citation Analysis]
112 Carrique L, Fan H, Walker AP, Keown JR, Sharps J, Staller E, Barclay WS, Fodor E, Grimes JM. Host ANP32A mediates the assembly of the influenza virus replicase. Nature 2020;587:638-43. [PMID: 33208942 DOI: 10.1038/s41586-020-2927-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
113 Batista da Silva Galdino A, do Nascimento Rangel AH, Buttar HS, Sales Lima Nascimento M, Cristina Gavioli E, Oliveira RDP, Cavalcanti Sales D, Urbano SA, Anaya K. Bovine colostrum: benefits for the human respiratory system and potential contributions for clinical management of COVID-19. Food and Agricultural Immunology 2021;32:143-62. [DOI: 10.1080/09540105.2021.1892594] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
114 Spieler EE, Moritz E, Stertz S, Hale BG. Application of a Biologically Contained Reporter System To Study Gain-of-Function H5N1 Influenza A Viruses with Pandemic Potential. mSphere 2020;5:e00423-20. [PMID: 32848003 DOI: 10.1128/mSphere.00423-20] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
115 Trigueiro-Louro J, Santos LA, Almeida F, Correia V, Brito RMM, Rebelo-de-Andrade H. NS1 protein as a novel anti-influenza target: Map-and-mutate antiviral rationale reveals new putative druggable hot spots with an important role on viral replication. Virology 2022;565:106-16. [PMID: 34773868 DOI: 10.1016/j.virol.2021.11.001] [Reference Citation Analysis]
116 Uprety T, Sreenivasan CC, Bhattarai S, Wang D, Kaushik RS, Li F. Isolation and development of bovine primary respiratory cells as model to study influenza D virus infection. Virology 2021;559:89-99. [PMID: 33862336 DOI: 10.1016/j.virol.2021.04.003] [Reference Citation Analysis]
117 Ma Y, Wang Y, Dong C, Gonzalez GX, Song Y, Zhu W, Kim J, Wei L, Wang BZ. Influenza NP core and HA or M2e shell double-layered protein nanoparticles induce broad protection against divergent influenza A viruses. Nanomedicine 2021;40:102479. [PMID: 34743020 DOI: 10.1016/j.nano.2021.102479] [Reference Citation Analysis]
118 Walters KA, Zhu R, Welge M, Scherler K, Park JK, Rahil Z, Wang H, Auvil L, Bushell C, Lee MY, Baxter D, Bristol T, Rosas LA, Cervantes-Medina A, Czajkowski L, Han A, Memoli MJ, Taubenberger JK, Kash JC. Differential Effects of Influenza Virus NA, HA Head, and HA Stalk Antibodies on Peripheral Blood Leukocyte Gene Expression during Human Infection. mBio 2019;10:e00760-19. [PMID: 31088926 DOI: 10.1128/mBio.00760-19] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
119 Zhan W, Muhuri M, Tai PWL, Gao G. Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens? Front Immunol 2021;12:673699. [PMID: 34046041 DOI: 10.3389/fimmu.2021.673699] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
120 Bamunuarachchi G, Pushparaj S, Liu L. Interplay between host non-coding RNAs and influenza viruses. RNA Biol 2021;18:767-84. [PMID: 33404285 DOI: 10.1080/15476286.2021.1872170] [Reference Citation Analysis]
121 Axelsson KF, Litsne H, Lorentzon M. Fractures and fall injuries after hospitalization for seasonal influenza-a national retrospective cohort study. Osteoporos Int 2021. [PMID: 34436639 DOI: 10.1007/s00198-021-06068-1] [Reference Citation Analysis]
122 Yan LM, Lau SPN, Poh CM, Chan VSF, Chan MCW, Peiris M, Poon LLM. Heterosubtypic Protection Induced by a Live Attenuated Influenza Virus Vaccine Expressing Galactose-α-1,3-Galactose Epitopes in Infected Cells. mBio 2020;11:e00027-20. [PMID: 32127444 DOI: 10.1128/mBio.00027-20] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
123 Khoshnood S, Shirani M, Dalir A, Moradi M, Haddadi MH, Sadeghifard N, Birjandi FS, Yashmi I, Heidary M. Antiviral effects of azithromycin: A narrative review. Biomedicine & Pharmacotherapy 2022;147:112682. [DOI: 10.1016/j.biopha.2022.112682] [Reference Citation Analysis]
124 Wiggins KB, Smith MA, Schultz-Cherry S. The Nature of Immune Responses to Influenza Vaccination in High-Risk Populations. Viruses 2021;13:1109. [PMID: 34207924 DOI: 10.3390/v13061109] [Reference Citation Analysis]
125 Mackerracher A, Sommershof A, Groettrup M. PLGA particle vaccination elicits resident memory CD8 T cells protecting from tumors and infection. European Journal of Pharmaceutical Sciences 2022. [DOI: 10.1016/j.ejps.2022.106209] [Reference Citation Analysis]
126 Palomba E, Castelli V, Renisi G, Bandera A, Lombardi A, Gori A. Antiviral Treatments for Influenza. Semin Respir Crit Care Med 2021;42:859-72. [PMID: 34918326 DOI: 10.1055/s-0041-1733830] [Reference Citation Analysis]
127 Kang M, Zanin M, Wong S. Subtype H3N2 Influenza A Viruses: An Unmet Challenge in the Western Pacific. Vaccines 2022;10:112. [DOI: 10.3390/vaccines10010112] [Reference Citation Analysis]
128 Bukasov R, Dossym D, Filchakova O. Detection of RNA viruses from influenza and HIV to Ebola and SARS-CoV-2: a review. Anal Methods 2021;13:34-55. [DOI: 10.1039/d0ay01886d] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
129 Krammer F. The human antibody response to influenza A virus infection and vaccination. Nat Rev Immunol 2019;19:383-97. [PMID: 30837674 DOI: 10.1038/s41577-019-0143-6] [Cited by in Crossref: 162] [Cited by in F6Publishing: 149] [Article Influence: 81.0] [Reference Citation Analysis]
130 Dolskiy AA, Grishchenko IV, Yudkin DV. Cell Cultures for Virology: Usability, Advantages, and Prospects. Int J Mol Sci 2020;21:E7978. [PMID: 33121109 DOI: 10.3390/ijms21217978] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
131 Zeigler DF, Gage E, Clegg CH. Epitope-targeting platform for broadly protective influenza vaccines. PLoS One 2021;16:e0252170. [PMID: 34043704 DOI: 10.1371/journal.pone.0252170] [Reference Citation Analysis]
132 Cezard A, Guillon A, Si-Tahar M. [Identification of a metabolic immune regulator in the host that protects against influenzal pneumonia]. Rev Mal Respir 2021;38:567-71. [PMID: 34024644 DOI: 10.1016/j.rmr.2021.05.003] [Reference Citation Analysis]
133 Broecker F, Moelling K. What viruses tell us about evolution and immunity: beyond Darwin? Ann N Y Acad Sci 2019;1447:53-68. [PMID: 31032941 DOI: 10.1111/nyas.14097] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
134 Yang J, Du J, Huang C, Wang T, Huang L, Yang S, Li L. Discovery of 5-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrazin-2(1H)-one derivatives as new potent PB2 inhibitors. Bioorganic & Medicinal Chemistry Letters 2019;29:1609-13. [DOI: 10.1016/j.bmcl.2019.04.042] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
135 Aydillo T, Escalera A, Strohmeier S, Aslam S, Sanchez-Cespedes J, Ayllon J, Roca-Oporto C, Perez-Romero P, Montejo M, Gavalda J, Munoz P, Lopez-Medrano F, Carratala J, Krammer F, García-Sastre A, Cordero E. Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients. Cell Rep Med 2020;1:100130. [PMID: 33294855 DOI: 10.1016/j.xcrm.2020.100130] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
136 Bisset AT, Hoyne GF. Evolution and Adaptation of the Avian H7N9 Virus into the Human Host. Microorganisms 2020;8:E778. [PMID: 32455845 DOI: 10.3390/microorganisms8050778] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
137 Nickol ME, Lyle SM, Dennehy B, Kindrachuk J. Dysregulated Host Responses Underlie 2009 Pandemic Influenza-Methicillin Resistant Staphylococcus aureus Coinfection Pathogenesis at the Alveolar-Capillary Barrier. Cells 2020;9:E2472. [PMID: 33202895 DOI: 10.3390/cells9112472] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
138 Kang D, Ahn HJ, Lee J, Kim SK, Pyun J, Song CS, Kim SJ, Lee J. An NIR dual-emitting/absorbing inorganic compact pair: A self-calibrating LRET system for homogeneous virus detection. Biosens Bioelectron 2021;190:113369. [PMID: 34098357 DOI: 10.1016/j.bios.2021.113369] [Reference Citation Analysis]
139 Al-Salihi SAA, Alberti F. Naturally Occurring Terpenes: A Promising Class of Organic Molecules to Address Influenza Pandemics. Nat Prod Bioprospect 2021;11:405-19. [PMID: 33939136 DOI: 10.1007/s13659-021-00306-z] [Reference Citation Analysis]
140 Bischof E, Siow RC, Zhavoronkov A, Kaeberlein M. The potential of rapalogs to enhance resilience against SARS-CoV-2 infection and reduce the severity of COVID-19. Lancet Healthy Longev 2021;2:e105-11. [PMID: 33665645 DOI: 10.1016/S2666-7568(20)30068-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
141 Park BR, Kim KH, Kotomina T, Kim MC, Kwon YM, Jeeva S, Jung YJ, Bhatnagar N, Isakova-Sivak I, Mezhenskaya D, Rudenko L, Wang BZ, Kang SM. Broad cross protection by recombinant live attenuated influenza H3N2 seasonal virus expressing conserved M2 extracellular domain in a chimeric hemagglutinin. Sci Rep 2021;11:4151. [PMID: 33603072 DOI: 10.1038/s41598-021-83704-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
142 Lindahl G. Subdominance in Antibody Responses: Implications for Vaccine Development. Microbiol Mol Biol Rev 2020;85:e00078-20. [PMID: 33239435 DOI: 10.1128/MMBR.00078-20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
143 Murphy-Schafer AR, Paust S. Divergent Mast Cell Responses Modulate Antiviral Immunity During Influenza Virus Infection. Front Cell Infect Microbiol 2021;11:580679. [PMID: 33680987 DOI: 10.3389/fcimb.2021.580679] [Reference Citation Analysis]
144 Frymus T, Belák S, Egberink H, Hofmann-Lehmann R, Marsilio F, Addie DD, Boucraut-Baralon C, Hartmann K, Lloret A, Lutz H, Pennisi MG, Thiry E, Truyen U, Tasker S, Möstl K, Hosie MJ. Influenza Virus Infections in Cats. Viruses 2021;13:1435. [PMID: 34452300 DOI: 10.3390/v13081435] [Reference Citation Analysis]
145 Tsuneki-Tokunaga A, Kondo T, Kanai K, Itagaki A, Tsuchie H, Okada T, Kasagi M, Tanaka K, Hinay AJA, Kageyama S. Local spread of influenza A (H1N1) viruses without a mutation for the maximum duration of an epidemic season in Japan. Arch Virol 2021. [PMID: 34761287 DOI: 10.1007/s00705-021-05301-w] [Reference Citation Analysis]
146 Nitika, Wei J, Hui AM. The Development of mRNA Vaccines for Infectious Diseases: Recent Updates. Infect Drug Resist 2021;14:5271-85. [PMID: 34916811 DOI: 10.2147/IDR.S341694] [Reference Citation Analysis]
147 Misra RS, Nayak JL. The Importance of Vaccinating Children and Pregnant Women against Influenza Virus Infection. Pathogens 2019;8:E265. [PMID: 31779153 DOI: 10.3390/pathogens8040265] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
148 Julander JG, Demarest JF, Taylor R, Gowen BB, Walling DM, Mathis A, Babu YS. An update on the progress of galidesivir (BCX4430), a broad-spectrum antiviral. Antiviral Res 2021;195:105180. [PMID: 34551346 DOI: 10.1016/j.antiviral.2021.105180] [Reference Citation Analysis]
149 Lamotte LA, Tafforeau L. How Influenza A Virus NS1 Deals with the Ubiquitin System to Evade Innate Immunity. Viruses 2021;13:2309. [PMID: 34835115 DOI: 10.3390/v13112309] [Reference Citation Analysis]
150 Broecker F, Zheng A, Suntronwong N, Sun W, Bailey MJ, Krammer F, Palese P. Extending the Stalk Enhances Immunogenicity of the Influenza Virus Neuraminidase. J Virol 2019;93:e00840-19. [PMID: 31375573 DOI: 10.1128/JVI.00840-19] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
151 Pizzorno A, Padey B, Terrier O, Rosa-Calatrava M. Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy. Front Immunol 2019;10:531. [PMID: 30941148 DOI: 10.3389/fimmu.2019.00531] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 16.0] [Reference Citation Analysis]
152 Shibuya M, Tamiya S, Kawai A, Hirai T, Cragg MS, Yoshioka Y. Synergistic effect of non-neutralizing antibodies and interferon-γ for cross-protection against influenza. iScience 2021;24:103131. [PMID: 34622175 DOI: 10.1016/j.isci.2021.103131] [Reference Citation Analysis]
153 Latreille E, Lee WL. Interactions of Influenza and SARS-CoV-2 with the Lung Endothelium: Similarities, Differences, and Implications for Therapy. Viruses. 2021;13. [PMID: 33499234 DOI: 10.3390/v13020161] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
154 Basavaraju S, Mishra S, Jindal R, Kesavardhana S. Emerging Role of ZBP1 in Z-RNA Sensing, Influenza Virus-Induced Cell Death, and Pulmonary Inflammation. mBio 2022;:e0040122. [PMID: 35587190 DOI: 10.1128/mbio.00401-22] [Reference Citation Analysis]
155 Casanova JL, Abel L. The human genetic determinism of life-threatening infectious diseases: genetic heterogeneity and physiological homogeneity? Hum Genet 2020;139:681-94. [PMID: 32462426 DOI: 10.1007/s00439-020-02184-w] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
156 Hensen L, Kedzierska K, Koutsakos M. Innate and adaptive immunity toward influenza B viruses. Future Microbiology 2020;15:1045-58. [DOI: 10.2217/fmb-2019-0340] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
157 Alberione MP, Moeller R, Kirui J, Ginkel C, Doepke M, Ströh LJ, Machtens JP, Pietschmann T, Gerold G. Single-nucleotide variants in human CD81 influence hepatitis C virus infection of hepatoma cells. Med Microbiol Immunol 2020;209:499-514. [PMID: 32322956 DOI: 10.1007/s00430-020-00675-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
158 Sicca F, Martinuzzi D, Montomoli E, Huckriede A. Comparison of influenza-specific neutralizing antibody titers determined using different assay readouts and hemagglutination inhibition titers: good correlation but poor agreement. Vaccine 2020;38:2527-41. [PMID: 32044163 DOI: 10.1016/j.vaccine.2020.01.088] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
159 Tarasov M, Shanko A, Kordyukova L, Katlinski A. Characterization of Inactivated Influenza Vaccines Used in the Russian National Immunization Program. Vaccines (Basel) 2020;8:E488. [PMID: 32872645 DOI: 10.3390/vaccines8030488] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
160 Vaghari-Tabari M, Mohammadzadeh I, Qujeq D, Majidinia M, Alemi F, Younesi S, Mahmoodpoor A, Maleki M, Yousefi B, Asemi Z. Vitamin D in respiratory viral infections: a key immune modulator? Crit Rev Food Sci Nutr 2021;:1-16. [PMID: 34470511 DOI: 10.1080/10408398.2021.1972407] [Reference Citation Analysis]
161 Zhang J, Ding D, Huang X, Zhang J, Chen D, Fu P, Shi Y, Xu W, Tao Z. Differentiation of COVID-19 from seasonal influenza: A multicenter comparative study. J Med Virol 2021;93:1512-9. [PMID: 32856744 DOI: 10.1002/jmv.26469] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
162 Irvine EB, Alter G. Understanding the role of antibody glycosylation through the lens of severe viral and bacterial diseases. Glycobiology 2020;30:241-53. [PMID: 32103252 DOI: 10.1093/glycob/cwaa018] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
163 Song Y, Zhang Y, Zhang B, Chen L, Zhang M, Wang J, Jiang Y, Yang C, Jiang T. Identification, Genetic Analysis, and Pathogenicity of Classical Swine H1N1 and Human-Swine Reassortant H1N1 Influenza Viruses from Pigs in China. Viruses 2020;12:E55. [PMID: 31906591 DOI: 10.3390/v12010055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
164 Gärtner BC, Sester M. Diversity of antibody responses after influenza infection or vaccination-Needed or nice to have? Am J Transplant 2021;21:2631-2. [PMID: 33638930 DOI: 10.1111/ajt.16554] [Reference Citation Analysis]
165 Shuid AN, Jayusman PA, Shuid N, Ismail J, Kamal Nor N, Mohamed IN. Association between Viral Infections and Risk of Autistic Disorder: An Overview. Int J Environ Res Public Health 2021;18:2817. [PMID: 33802042 DOI: 10.3390/ijerph18062817] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
166 Ochnik M, Franz D, Sobczyński M, Naporowski P, Banach M, Orzechowska B, Sochocka M. Inhibition of Human Respiratory Influenza A Virus and Human Betacoronavirus-1 by the Blend of Double-Standardized Extracts of Aronia melanocarpa (Michx.) Elliot and Sambucus nigra L. Pharmaceuticals 2022;15:619. [DOI: 10.3390/ph15050619] [Reference Citation Analysis]
167 Chua SCJH, Cui J, Engelberg D, Lim LHK. A Review and Meta-Analysis of Influenza Interactome Studies. Front Microbiol 2022;13:869406. [DOI: 10.3389/fmicb.2022.869406] [Reference Citation Analysis]
168 Javanian M, Barary M, Ghebrehewet S, Koppolu V, Vasigala V, Ebrahimpour S. A brief review of influenza virus infection. J Med Virol 2021;93:4638-46. [PMID: 33792930 DOI: 10.1002/jmv.26990] [Reference Citation Analysis]
169 Zhou X, Zhao M, Liu Y, Chen Q, Shen L. Statistical Binding Matching between Influenza A Virus and Dynamic Glycan Clusters Determines Its Adhesion onto Lipid Membranes. Langmuir 2020;36:15212-9. [PMID: 33307709 DOI: 10.1021/acs.langmuir.0c02047] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
170 Schroff P, Hovey JR, Tharumia Jagadeesan C, Nagalapuram V, Chaucer B. Cardiac Tamponade Secondary to Influenza B Infection. Cureus 2021;13:e14888. [PMID: 34109077 DOI: 10.7759/cureus.14888] [Reference Citation Analysis]
171 Cheng C, Holyoak M, Xu L, Li J, Liu W, Stenseth NC, Zhang Z. Host and geographic barriers shape the competition, coexistence, and extinction patterns of influenza A (H1N1) viruses. Ecology and Evolution 2022;12. [DOI: 10.1002/ece3.8732] [Reference Citation Analysis]
172 Campos JHC, Maricato JT, Braconi CT, Antoneli F, Janini LMR, Briones MRS. Direct RNA Sequencing Reveals SARS-CoV-2 m6A Sites and Possible Differential DRACH Motif Methylation among Variants. Viruses 2021;13:2108. [PMID: 34834915 DOI: 10.3390/v13112108] [Reference Citation Analysis]
173 Kolosova NP, Ilyicheva TN, Danilenko AV, Bulanovich JA, Svyatchenko SV, Durymanov AG, Goncharova NI, Gudymo AS, Shvalov AN, Susloparov IM, Marchenko VY, Tregubchak TV, Gavrilova EV, Maksyutov RA, Ryzhikov AB. Severe cases of seasonal influenza in Russia in 2017-2018. PLoS One 2019;14:e0220401. [PMID: 31356626 DOI: 10.1371/journal.pone.0220401] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
174 Oh S, Lee E, Park J, Lee JK, Cho GJ, Park I, Shin OS. Anti-Viral Activities of Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Against Human Respiratory Viruses. Front Cell Infect Microbiol 2022;12:850744. [DOI: 10.3389/fcimb.2022.850744] [Reference Citation Analysis]
175 Wang B, Su Q, Luo J, Li M, Wu Q, Chang H, Du J, Huang C, Ma J, Han S, Yuan G, He Y, Guo M, Zhang Q, He H. Differences in Highly Pathogenic H5N6 Avian Influenza Viral Pathogenicity and Inflammatory Response in Chickens and Ducks. Front Microbiol 2021;12:593202. [PMID: 33584608 DOI: 10.3389/fmicb.2021.593202] [Reference Citation Analysis]
176 Tapia R, Torremorell M, Culhane M, Medina RA, Neira V. Antigenic characterization of novel H1 influenza A viruses in swine. Sci Rep 2020;10:4510. [PMID: 32161289 DOI: 10.1038/s41598-020-61315-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
177 Nicholls CMR, Sevvana M, Kuhn RJ. Structure-guided paradigm shifts in flavivirus assembly and maturation mechanisms. Adv Virus Res 2020;108:33-83. [PMID: 33837721 DOI: 10.1016/bs.aivir.2020.08.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
178 Koutsakos M, Nguyen THO, Kedzierska K. With a Little Help from T Follicular Helper Friends: Humoral Immunity to Influenza Vaccination. J Immunol 2019;202:360-7. [PMID: 30617117 DOI: 10.4049/jimmunol.1800986] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 10.0] [Reference Citation Analysis]
179 Correia W, Dorta-Guerra R, Sanches M, Almeida Semedo CJB, Valladares B, de Pina-Araújo IIM, Carmelo E. Study of the Etiology of Acute Respiratory Infections in Children Under 5 Years at the Dr. Agostinho Neto Hospital, Praia, Santiago Island, Cabo Verde. Front Pediatr 2021;9:716351. [PMID: 34650939 DOI: 10.3389/fped.2021.716351] [Reference Citation Analysis]
180 Noor R, Maniha SM. A brief outline of respiratory viral disease outbreaks: 1889-till date on the public health perspectives. Virusdisease 2020;:1-9. [PMID: 32905186 DOI: 10.1007/s13337-020-00628-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
181 Casalino-Matsuda SM, Chen F, Gonzalez-Gonzalez FJ, Nair A, Dib S, Yemelyanov A, Gates KL, Budinger GRS, Beitel GJ, Sporn PHS. Hypercapnia Suppresses Macrophage Antiviral Activity and Increases Mortality of Influenza A Infection via Akt1. J Immunol 2020;205:489-501. [PMID: 32540997 DOI: 10.4049/jimmunol.2000085] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
182 van de Sandt CE, Clemens EB, Grant EJ, Rowntree LC, Sant S, Halim H, Crowe J, Cheng AC, Kotsimbos TC, Richards M, Miller A, Tong SYC, Rossjohn J, Nguyen THO, Gras S, Chen W, Kedzierska K. Challenging immunodominance of influenza-specific CD8+ T cell responses restricted by the risk-associated HLA-A*68:01 allomorph. Nat Commun 2019;10:5579. [PMID: 31811120 DOI: 10.1038/s41467-019-13346-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
183 Liu H, Plancarte M, Ball EE, Weiss CM, Gonzales-Viera O, Holcomb K, Ma ZM, Allen AM, Reader JR, Duignan PJ, Halaska B, Khan Z, Kriti D, Dutta J, van Bakel H, Jackson K, Pesavento PA, Boyce WM, Coffey LL. Respiratory Tract Explant Infection Dynamics of Influenza A Virus in California Sea Lions, Northern Elephant Seals, and Rhesus Macaques. J Virol 2021;95:e0040321. [PMID: 34037419 DOI: 10.1128/JVI.00403-21] [Reference Citation Analysis]
184 Iyer S, Yadav R, Agarwal S, Tripathi S, Agarwal R. Bioengineering Strategies for Developing Vaccines against Respiratory Viral Diseases. Clin Microbiol Rev 2021;:e0012321. [PMID: 34788128 DOI: 10.1128/CMR.00123-21] [Reference Citation Analysis]
185 Mifsud EJ, Kuba M, Barr IG. Innate Immune Responses to Influenza Virus Infections in the Upper Respiratory Tract. Viruses 2021;13:2090. [PMID: 34696520 DOI: 10.3390/v13102090] [Reference Citation Analysis]
186 Lipsitch M, Krammer F, Regev-Yochay G, Lustig Y, Balicer RD. SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact. Nat Rev Immunol 2021. [PMID: 34876702 DOI: 10.1038/s41577-021-00662-4] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
187 Gallego I, Lostalé-Seijo I, Montenegro J. Stronger Together: Multivalent Phage Capsids Inhibit Virus Entry. Chembiochem 2021;22:478-80. [PMID: 32856365 DOI: 10.1002/cbic.202000536] [Reference Citation Analysis]
188 Janik E, Ceremuga M, Niemcewicz M, Bijak M. Dangerous Pathogens as a Potential Problem for Public Health. Medicina (Kaunas) 2020;56:E591. [PMID: 33172013 DOI: 10.3390/medicina56110591] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
189 Jung YJ, Kim KH, Ko EJ, Lee Y, Kim MC, Lee YT, Kim CH, Jeeva S, Park BR, Kang SM. Adjuvant effects of killed Lactobacillus casei DK128 on enhancing T helper type 1 immune responses and the efficacy of influenza vaccination in normal and CD4-deficient mice. Vaccine 2020;38:5783-92. [PMID: 32674907 DOI: 10.1016/j.vaccine.2020.06.075] [Reference Citation Analysis]
190 Tiwary M, Rooney RJ, Liedmann S, LeMessurier KS, Samarasinghe AE. Eosinophil Responses at the Airway Epithelial Barrier during the Early Phase of Influenza A Virus Infection in C57BL/6 Mice. Cells 2021;10:509. [PMID: 33673645 DOI: 10.3390/cells10030509] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
191 McCartney MM, Linderholm AL, Yamaguchi MS, Falcon AK, Harper RW, Thompson GR, Ebeler SE, Kenyon NJ, Davis CE, Schivo M. Predicting influenza and rhinovirus infections in airway cells utilizing volatile emissions. J Infect Dis 2021:jiab205. [PMID: 33858010 DOI: 10.1093/infdis/jiab205] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
192 Koutsakos M, Kent SJ. Influenza B viruses: underestimated and overlooked. Microbiol Aust 2021;42:110. [DOI: 10.1071/ma21033] [Reference Citation Analysis]
193 Liu YC, Mok BW, Wang P, Kuo RL, Chen H, Shih SR. Cellular 5'-3' mRNA Exoribonuclease XRN1 Inhibits Interferon Beta Activation and Facilitates Influenza A Virus Replication. mBio 2021;12:e0094521. [PMID: 34311580 DOI: 10.1128/mBio.00945-21] [Reference Citation Analysis]
194 Biondo C, Lentini G, Beninati C, Teti G. The dual role of innate immunity during influenza. Biomed J 2019;42:8-18. [PMID: 30987709 DOI: 10.1016/j.bj.2018.12.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
195 Blot M, Chavanet P, Piroth L. [Influenza infection: An update for clinicians]. Rev Med Interne 2019;40:158-65. [PMID: 30638964 DOI: 10.1016/j.revmed.2018.12.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
196 Hirschenberger M, Hunszinger V, Sparrer KMJ. Implications of Innate Immunity in Post-Acute Sequelae of Non-Persistent Viral Infections. Cells 2021;10:2134. [PMID: 34440903 DOI: 10.3390/cells10082134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
197 Strohmeier S, Amanat F, Zhu X, McMahon M, Deming ME, Pasetti MF, Neuzil KM, Wilson IA, Krammer F. A Novel Recombinant Influenza Virus Neuraminidase Vaccine Candidate Stabilized by a Measles Virus Phosphoprotein Tetramerization Domain Provides Robust Protection from Virus Challenge in the Mouse Model. mBio 2021;12:e0224121. [PMID: 34809451 DOI: 10.1128/mBio.02241-21] [Reference Citation Analysis]
198 Huang D, Liu T, Liao J, Maharjan S, Xie X, Pérez M, Anaya I, Wang S, Tirado Mayer A, Kang Z, Kong W, Mainardi VL, Garciamendez-Mijares CE, García Martínez G, Moretti M, Zhang W, Gu Z, Ghaemmaghami AM, Zhang YS. Reversed-engineered human alveolar lung-on-a-chip model. Proc Natl Acad Sci U S A 2021;118:e2016146118. [PMID: 33941687 DOI: 10.1073/pnas.2016146118] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
199 de Jesus JR, de Araújo Andrade T. Understanding the relationship between viral infections and trace elements from a metallomics perspective: implications for COVID-19. Metallomics 2020;12:1912-30. [PMID: 33295922 DOI: 10.1039/d0mt00220h] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
200 Murtas R, Decarli A, Russo AG. Trend of pneumonia diagnosis in emergency departments as a COVID-19 surveillance system: a time series study. BMJ Open 2021;11:e044388. [PMID: 33558358 DOI: 10.1136/bmjopen-2020-044388] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
201 Elshina E, Te Velthuis AJW. The influenza virus RNA polymerase as an innate immune agonist and antagonist. Cell Mol Life Sci 2021. [PMID: 34677644 DOI: 10.1007/s00018-021-03957-w] [Reference Citation Analysis]
202 Mahallawi WH, Ibrahim NA, Alahmadi KS, Al-Harbi AK, Almughthawi MA, Alhazmi OA, Alsehli FH, Khabour OF. Natural immunity to influenza A and B among Saudi blood donors in Al Madinah Al Munawarah, Saudi Arabia. Saudi Med J 2020;41:1301-7. [PMID: 33294887 DOI: 10.15537/smj.2020.12.05582] [Reference Citation Analysis]
203 Salazar F, Bignell E, Brown GD, Cook PC, Warris A. Pathogenesis of Respiratory Viral and Fungal Coinfections. Clin Microbiol Rev 2021;:e0009421. [PMID: 34788127 DOI: 10.1128/CMR.00094-21] [Reference Citation Analysis]
204 Martins LD, da Silva I, Batista WV, Andrade MF, Freitas ED, Martins JA. How socio-economic and atmospheric variables impact COVID-19 and influenza outbreaks in tropical and subtropical regions of Brazil. Environ Res 2020;191:110184. [PMID: 32946893 DOI: 10.1016/j.envres.2020.110184] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 7.5] [Reference Citation Analysis]
205 Si L, Bai H, Oh CY, Jin L, Prantil-Baun R, Ingber DE. Clinically Relevant Influenza Virus Evolution Reconstituted in a Human Lung Airway-on-a-Chip. Microbiol Spectr 2021;9:e0025721. [PMID: 34523991 DOI: 10.1128/Spectrum.00257-21] [Reference Citation Analysis]
206 Lin PH, Liang CY, Yao BY, Chen HW, Pan CF, Wu LL, Lin YH, Hsu YS, Liu YH, Chen PJ, Hu CJ, Yang HC. Robust induction of TRMs by combinatorial nanoshells confers cross-strain sterilizing immunity against lethal influenza viruses. Mol Ther Methods Clin Dev 2021;21:299-314. [PMID: 33898629 DOI: 10.1016/j.omtm.2021.03.010] [Reference Citation Analysis]
207 Kalkan Yazıcı M, Koç MM, Çetin NS, Karaaslan E, Okay G, Durdu B, Sümbül B, Doymaz MZ. Discordance between Serum Neutralizing Antibody Titers and the Recovery from COVID-19. J Immunol 2020;205:2719-25. [PMID: 32978281 DOI: 10.4049/jimmunol.2000840] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
208 Singh B, Kaur P, Reid RJ, Shamoon F, Bikkina M. COVID-19 and Influenza Co-Infection: Report of Three Cases.Cureus. 2020;12:e9852. [PMID: 32832306 DOI: 10.7759/cureus.9852] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
209 Du R, Cui Q, Rong L. Flu Universal Vaccines: New Tricks on an Old Virus. Virol Sin 2021;36:13-24. [PMID: 32870450 DOI: 10.1007/s12250-020-00283-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
210 Lu W, Pieters RJ. Carbohydrate–protein interactions and multivalency: implications for the inhibition of influenza A virus infections. Expert Opinion on Drug Discovery 2019;14:387-95. [DOI: 10.1080/17460441.2019.1573813] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
211 Lin X, Lin F, Liang T, Ducatez MF, Zanin M, Wong SS. Antibody Responsiveness to Influenza: What Drives It? Viruses 2021;13:1400. [PMID: 34372607 DOI: 10.3390/v13071400] [Reference Citation Analysis]
212 Kalonda A, Phonera M, Saasa N, Kajihara M, Sutcliffe CG, Sawa H, Takada A, Simulundu E. Influenza A and D Viruses in Non-Human Mammalian Hosts in Africa: A Systematic Review and Meta-Analysis. Viruses 2021;13:2411. [PMID: 34960680 DOI: 10.3390/v13122411] [Reference Citation Analysis]
213 Mifsud EJ, Hayden FG, Hurt AC. Antivirals targeting the polymerase complex of influenza viruses. Antiviral Res 2019;169:104545. [PMID: 31247246 DOI: 10.1016/j.antiviral.2019.104545] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 20.3] [Reference Citation Analysis]
214 Seidah NG, Pasquato A, Andréo U. How Do Enveloped Viruses Exploit the Secretory Proprotein Convertases to Regulate Infectivity and Spread? Viruses 2021;13:1229. [PMID: 34202098 DOI: 10.3390/v13071229] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
215 Bohálová N, Cantara A, Bartas M, Kaura P, Šťastný J, Pečinka P, Fojta M, Mergny JL, Brázda V. Analyses of viral genomes for G-quadruplex forming sequences reveal their correlation with the type of infection. Biochimie 2021;186:13-27. [PMID: 33839192 DOI: 10.1016/j.biochi.2021.03.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
216 Aledavood E, Selmi B, Estarellas C, Masetti M, Luque FJ. From Acid Activation Mechanisms of Proton Conduction to Design of Inhibitors of the M2 Proton Channel of Influenza A Virus. Front Mol Biosci 2022;8:796229. [DOI: 10.3389/fmolb.2021.796229] [Reference Citation Analysis]
217 Postoak JL, Yang G, Wu L, Van Kaer L. Cellular self-cannibalism helps immune cells fight the flu. FEBS J 2021;288:3154-8. [PMID: 33411418 DOI: 10.1111/febs.15641] [Reference Citation Analysis]
218 Bai H, Si L, Jiang A, Belgur C, Zhai Y, Plebani R, Oh CY, Rodas M, Patil A, Nurani A, Gilpin SE, Powers RK, Goyal G, Prantil-Baun R, Ingber DE. Mechanical control of innate immune responses against viral infection revealed in a human lung alveolus chip. Nat Commun 2022;13:1928. [PMID: 35396513 DOI: 10.1038/s41467-022-29562-4] [Reference Citation Analysis]
219 Lamut A, Gjorgjieva M, Naesens L, Liekens S, Lillsunde K, Tammela P, Kikelj D, Tomašič T. Anti-influenza virus activity of benzo[d]thiazoles that target heat shock protein 90. Bioorganic Chemistry 2020;98:103733. [DOI: 10.1016/j.bioorg.2020.103733] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
220 Overeem NJ, Hamming PHE, Tieke M, van der Vries E, Huskens J. Multivalent Affinity Profiling: Direct Visualization of the Superselective Binding of Influenza Viruses. ACS Nano 2021;15:8525-36. [PMID: 33978406 DOI: 10.1021/acsnano.1c00166] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
221 Kanekiyo M, Ellis D, King NP. New Vaccine Design and Delivery Technologies. J Infect Dis 2019;219:S88-96. [PMID: 30715361 DOI: 10.1093/infdis/jiy745] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 14.5] [Reference Citation Analysis]
222 Hickerson BT, Adams SE, Barman S, Miller L, Lugovtsev VY, Webby RJ, Ince WL, Donnelly RP, Ilyushina NA. Pleiotropic Effects of Influenza H1, H3, and B Baloxavir-Resistant Substitutions on Replication, Sensitivity to Baloxavir, and Interferon Expression. Antimicrob Agents Chemother 2022;:e0000922. [PMID: 35262375 DOI: 10.1128/aac.00009-22] [Reference Citation Analysis]
223 Almeida A, Boattini M, Christaki E, Moreira Marques T, Moreira I, Cruz L, Tosatto V, Antão D, Bianco G, Iannaccone M, Costa C, Tsiolakkis G, Khattab E, Kasapi D, Ferreira AT, Cavallo R, Corte-Real R. Comparative virulence of seasonal viruses responsible for lower respiratory tract infections: a southern European multi-centre cohort study of hospital admissions. Infection 2021;49:483-90. [PMID: 33389699 DOI: 10.1007/s15010-020-01569-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
224 Bastard P. Why do people die from COVID-19? Science 2022;375:829-30. [PMID: 35201875 DOI: 10.1126/science.abn9649] [Reference Citation Analysis]
225 Liu Y, Song X, Li C, Hu H, Li W, Wang L, Hu J, Liao C, Liang H, He Z, Ye L. Chrysin Ameliorates Influenza Virus Infection in the Upper Airways by Repressing Virus-Induced Cell Cycle Arrest and Mitochondria-Dependent Apoptosis. Front Immunol 2022;13:872958. [DOI: 10.3389/fimmu.2022.872958] [Reference Citation Analysis]
226 O'Neill MB, Quach H, Pothlichet J, Aquino Y, Bisiaux A, Zidane N, Deschamps M, Libri V, Hasan M, Zhang SY, Zhang Q, Matuozzo D, Cobat A, Abel L, Casanova JL, Naffakh N, Rotival M, Quintana-Murci L. Single-Cell and Bulk RNA-Sequencing Reveal Differences in Monocyte Susceptibility to Influenza A Virus Infection Between Africans and Europeans. Front Immunol 2021;12:768189. [PMID: 34912340 DOI: 10.3389/fimmu.2021.768189] [Reference Citation Analysis]
227 Naguib MM, Verhagen JH, Mostafa A, Wille M, Li R, Graaf A, Järhult JD, Ellström P, Zohari S, Lundkvist Å, Olsen B. Global patterns of avian influenza A (H7): virus evolution and zoonotic threats. FEMS Microbiol Rev 2019;43:608-21. [PMID: 31381759 DOI: 10.1093/femsre/fuz019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
228 Broecker F, Liu STH, Suntronwong N, Sun W, Bailey MJ, Nachbagauer R, Krammer F, Palese P. A mosaic hemagglutinin-based influenza virus vaccine candidate protects mice from challenge with divergent H3N2 strains. NPJ Vaccines 2019;4:31. [PMID: 31341648 DOI: 10.1038/s41541-019-0126-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
229 Zhang L, Chen J, Ke C, Zhang H, Zhang S, Tang W, Liu C, Liu G, Chen S, Hu A, Sun W, Xiao Y, Liu M, Chen X. Ethanol Extract of Caesalpinia decapetala Inhibits Influenza Virus Infection In Vitro and In Vivo. Viruses 2020;12:E557. [PMID: 32443510 DOI: 10.3390/v12050557] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
230 Worobey M, Plotkin S, Hensley SE. Influenza Vaccines Delivered in Early Childhood Could Turn Antigenic Sin into Antigenic Blessings. Cold Spring Harb Perspect Med 2020;10:a038471. [PMID: 31964642 DOI: 10.1101/cshperspect.a038471] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
231 Kiseleva I, Grigorieva E, Larionova N, Al Farroukh M, Rudenko L. COVID-19 in Light of Seasonal Respiratory Infections. Biology (Basel) 2020;9:E240. [PMID: 32825427 DOI: 10.3390/biology9090240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
232 Oliva J, Mettier J, Sedano L, Delverdier M, Bourgès-Abella N, Hause B, Loupias J, Pardo I, Bleuart C, Bordignon PJ, Meunier E, Le Goffic R, Meyer G, Ducatez MF. Murine Model for the Study of Influenza D Virus. J Virol 2020;94:e01662-19. [PMID: 31776281 DOI: 10.1128/JVI.01662-19] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
233 Zhao X, Zhao L, Zhao Y, Huang K, Gong W, Yang Y, Zhao L, Xia X, Li Z, Sheng F, Du X, Jin M. 3-Indoleacetonitrile Is Highly Effective in Treating Influenza A Virus Infection In Vitro and In Vivo. Viruses 2021;13:1433. [PMID: 34452298 DOI: 10.3390/v13081433] [Reference Citation Analysis]
234 Crisci E, Fraile L, Montoya M. Cellular Innate Immunity against PRRSV and Swine Influenza Viruses. Vet Sci 2019;6:E26. [PMID: 30862035 DOI: 10.3390/vetsci6010026] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
235 Nickol ME, Ciric J, Falcinelli SD, Chertow DS, Kindrachuk J. Characterization of Host and Bacterial Contributions to Lung Barrier Dysfunction Following Co-infection with 2009 Pandemic Influenza and Methicillin Resistant Staphylococcus aureus. Viruses 2019;11:E116. [PMID: 30699912 DOI: 10.3390/v11020116] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
236 Wang H, Tian Z, Xu Y, Wang Q, Ding SW, Li Y. Altering Intracellular Localization of the RNA Interference Factors by Influenza A Virus Non-structural Protein 1. Front Microbiol 2020;11:590904. [PMID: 33281788 DOI: 10.3389/fmicb.2020.590904] [Reference Citation Analysis]
237 George ST, Lai J, Ma J, Stacey HD, Miller MS, Mullarkey CE. Neutrophils and Influenza: A Thin Line between Helpful and Harmful. Vaccines (Basel) 2021;9:597. [PMID: 34199803 DOI: 10.3390/vaccines9060597] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
238 Abdulamir AS, Hafidh RR. The Possible Immunological Pathways for the Variable Immunopathogenesis of COVID—19 Infections among Healthy Adults, Elderly and Children. Electron J Gen Med 2020;17:em202. [DOI: 10.29333/ejgm/7850] [Cited by in Crossref: 68] [Cited by in F6Publishing: 22] [Article Influence: 34.0] [Reference Citation Analysis]
239 Ginex T, Luque FJ. Searching for effective antiviral small molecules against influenza A virus: A patent review. Expert Opin Ther Pat 2021;31:53-66. [PMID: 33012213 DOI: 10.1080/13543776.2020.1831471] [Reference Citation Analysis]
240 Rommel MGE, Milde C, Eberle R, Schulze H, Modlich U. Endothelial-platelet interactions in influenza-induced pneumonia: A potential therapeutic target. Anat Histol Embryol 2020;49:606-19. [PMID: 31793053 DOI: 10.1111/ahe.12521] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
241 Hirzel C, Chruscinski A, Ferreira VH, L'Huillier AG, Natori Y, Han SH, Cordero E, Humar A, Kumar D; Influenza in Transplant Study Group. Natural influenza infection produces a greater diversity of humoral responses than vaccination in immunosuppressed transplant recipients. Am J Transplant 2021;21:2709-18. [PMID: 33484237 DOI: 10.1111/ajt.16503] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
242 Broggi A, Granucci F, Zanoni I. Type III interferons: Balancing tissue tolerance and resistance to pathogen invasion. J Exp Med 2020;217:e20190295. [PMID: 31821443 DOI: 10.1084/jem.20190295] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 22.0] [Reference Citation Analysis]
243 Sieber P, Flury D, Güsewell S, Albrich WC, Boggian K, Gardiol C, Schlegel M, Sieber R, Vernazza P, Kohler P. Characteristics of patients with Coronavirus Disease 2019 (COVID-19) and seasonal influenza at time of hospital admission: a single center comparative study. BMC Infect Dis 2021;21:271. [PMID: 33731019 DOI: 10.1186/s12879-021-05957-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
244 Hou W, Lv L, Wang Y, Xing M, Guo Y, Xie D, Wei X, Zhang X, Liu H, Ren J, Zhou D. 6-Valent Virus-Like Particle-Based Vaccine Induced Potent and Sustained Immunity Against Noroviruses in Mice. Front Immunol 2022;13:906275. [DOI: 10.3389/fimmu.2022.906275] [Reference Citation Analysis]
245 Jiang W, Pilkington EH, Kelly HG, Tan HX, Juno JA, Wheatley AK, Kent SJ. Aggregation by peptide conjugation rescues poor immunogenicity of the HA stem. PLoS One 2020;15:e0241649. [PMID: 33137148 DOI: 10.1371/journal.pone.0241649] [Reference Citation Analysis]
246 Cao L, Zhao S, Lou J, Zheng H, Chan RWY, Chong MKC, Chen Z, Chan PKS, Zee BCY, Wang MH. Differential Influence of Age on the Relationship between Genetic Mismatch and A(H1N1)pdm09 Vaccine Effectiveness. Viruses 2021;13:619. [PMID: 33916601 DOI: 10.3390/v13040619] [Reference Citation Analysis]
247 Kerstetter LJ, Buckley S, Bliss CM, Coughlan L. Adenoviral Vectors as Vaccines for Emerging Avian Influenza Viruses. Front Immunol 2020;11:607333. [PMID: 33633727 DOI: 10.3389/fimmu.2020.607333] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
248 Tian X, Landreth S, Lu Y, Pandey K, Zhou Y. A Replication-Defective Influenza Virus Harboring H5 and H7 Hemagglutinins Provides Protection against H5N1 and H7N9 Infection in Mice. J Virol 2021;95:e02154-20. [PMID: 33177192 DOI: 10.1128/JVI.02154-20] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
249 [DOI: 10.1101/2020.07.01.182741] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
250 Lousa D, Pinto ART, Campos SRR, Baptista AM, Veiga AS, Castanho MARB, Soares CM. Effect of pH on the influenza fusion peptide properties unveiled by constant-pH molecular dynamics simulations combined with experiment. Sci Rep 2020;10:20082. [PMID: 33208852 DOI: 10.1038/s41598-020-77040-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
251 Reiter-Scherer V, Cuellar-Camacho JL, Bhatia S, Haag R, Herrmann A, Lauster D, Rabe JP. Force Spectroscopy Shows Dynamic Binding of Influenza Hemagglutinin and Neuraminidase to Sialic Acid. Biophys J 2019;116:1037-48. [PMID: 30799074 DOI: 10.1016/j.bpj.2019.01.041] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
252 Shibuya M, Tamiya S, Kawai A, Yoshioka Y. Nasal-subcutaneous prime-boost regimen for inactivated whole-virus influenza vaccine efficiently protects mice against both upper and lower respiratory tract infections. Biochem Biophys Res Commun 2021;554:166-72. [PMID: 33798943 DOI: 10.1016/j.bbrc.2021.03.099] [Reference Citation Analysis]
253 Dai X, Hakizimana O, Zhang X, Kaushik AC, Zhang J. Orchestrated efforts on host network hijacking: Processes governing virus replication. Virulence 2020;11:183-98. [PMID: 32050846 DOI: 10.1080/21505594.2020.1726594] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
254 Munnoli PM, Nabapure S, Yeshavanth G. Post-COVID-19 precautions based on lessons learned from past pandemics: a review. Z Gesundh Wiss 2020;:1-9. [PMID: 32837846 DOI: 10.1007/s10389-020-01371-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
255 Arunachalam AB, Post P, Rudin D. Unique features of a recombinant haemagglutinin influenza vaccine that influence vaccine performance. NPJ Vaccines 2021;6:144. [PMID: 34857771 DOI: 10.1038/s41541-021-00403-7] [Reference Citation Analysis]
256 Thompson AJ, Paulson JC. Adaptation of influenza viruses to human airway receptors. J Biol Chem 2021;296:100017. [PMID: 33144323 DOI: 10.1074/jbc.REV120.013309] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
257 Ashraf U, Benoit-Pilven C, Navratil V, Ligneau C, Fournier G, Munier S, Sismeiro O, Coppée JY, Lacroix V, Naffakh N. Influenza virus infection induces widespread alterations of host cell splicing. NAR Genom Bioinform 2020;2:lqaa095. [PMID: 33575639 DOI: 10.1093/nargab/lqaa095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
258 Tauran Y, Cerón-Carrasco JP, Rhimi M, Perret F, Kim B, Collard D, Coleman AW, Pérez-Sánchez H. Size and Flexibility Define the Inhibition of the H3N2 Influenza Endonuclease Enzyme by Calix[n]arenes. Antibiotics (Basel) 2019;8:E73. [PMID: 31163674 DOI: 10.3390/antibiotics8020073] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
259 Diefenbacher M, Tan TJC, Bauer DLV, Stadtmueller BM, Wu NC, Brooke CB. Interactions between Influenza A Virus Nucleoprotein and Gene Segment Untranslated Regions Facilitate Selective Modulation of Viral Gene Expression. J Virol 2022;:e0020522. [PMID: 35467364 DOI: 10.1128/jvi.00205-22] [Reference Citation Analysis]
260 Sun Y, Qin P, He J, Li W, Shi Y, Xu J, Wu Q, Chen Q, Li W, Wang X, Liu G, Chen W. Rapid and simultaneous visual screening of SARS-CoV-2 and influenza virufses with customized isothermal amplification integrated lateral flow strip. Biosens Bioelectron 2022;197:113771. [PMID: 34775255 DOI: 10.1016/j.bios.2021.113771] [Reference Citation Analysis]
261 Short KR, Kedzierska K, van de Sandt CE. Back to the Future: Lessons Learned From the 1918 Influenza Pandemic. Front Cell Infect Microbiol 2018;8:343. [PMID: 30349811 DOI: 10.3389/fcimb.2018.00343] [Cited by in Crossref: 94] [Cited by in F6Publishing: 75] [Article Influence: 23.5] [Reference Citation Analysis]
262 Koutsakos M, McWilliam HEG, Aktepe TE, Fritzlar S, Illing PT, Mifsud NA, Purcell AW, Rockman S, Reading PC, Vivian JP, Rossjohn J, Brooks AG, Mackenzie JM, Mintern JD, Villadangos JA, Nguyen THO, Kedzierska K. Downregulation of MHC Class I Expression by Influenza A and B Viruses. Front Immunol 2019;10:1158. [PMID: 31191533 DOI: 10.3389/fimmu.2019.01158] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 7.7] [Reference Citation Analysis]
263 Muñoz-Garcia J, Cochonneau D, Télétchéa S, Moranton E, Lanoe D, Brion R, Lézot F, Heymann MF, Heymann D. The twin cytokines interleukin-34 and CSF-1: masterful conductors of macrophage homeostasis. Theranostics 2021;11:1568-93. [PMID: 33408768 DOI: 10.7150/thno.50683] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
264 Silva CAT, Kamen AA, Henry O. Recent advances and current challenges in process intensification of cell culture‐based influenza virus vaccine manufacturing. Can J Chem Eng 2021;99:2525-35. [DOI: 10.1002/cjce.24197] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
265 Rathinasabapathy T, Sakthivel LP, Komarnytsky S. Plant-Based Support of Respiratory Health during Viral Outbreaks. J Agric Food Chem 2022. [PMID: 35147032 DOI: 10.1021/acs.jafc.1c06227] [Reference Citation Analysis]
266 Bartley JM, Cadar AN, Martin DE. Better, Faster, Stronger: mRNA Vaccines Show Promise for Influenza Vaccination in Older Adults. Immunol Invest 2021;50:810-20. [PMID: 33830864 DOI: 10.1080/08820139.2021.1909617] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
267 Urvashi, Senthil Kumar JB, Das P, Tandon V. Development of Azaindole-Based Frameworks as Potential Antiviral Agents and Their Future Perspectives. J Med Chem 2022. [PMID: 35477274 DOI: 10.1021/acs.jmedchem.2c00444] [Reference Citation Analysis]
268 Lopez CE, Legge KL. Influenza A Virus Vaccination: Immunity, Protection, and Recent Advances Toward A Universal Vaccine. Vaccines (Basel) 2020;8:E434. [PMID: 32756443 DOI: 10.3390/vaccines8030434] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
269 Ben Hamed S, Elargoubi A, Harrabi M, Srihi H, Souiai O, Mastouri M, Almalki MA, Gharbi J, Ben M'hadheb M. Phylogenetic analysis of the neuraminidase segment gene of Influenza A/H1N1 strains isolated from Monastir Region (Tunisia) during the 2017-2018 outbreak. Biologia (Bratisl) 2021;:1-10. [PMID: 33727729 DOI: 10.1007/s11756-021-00723-y] [Reference Citation Analysis]
270 An SH, Hong SM, Son SE, Song JH, Lee CY, Choi JG, Lee YJ, Jeong JH, Kim JB, Song CS, Kim JH, Choi KS, Kwon HJ. Improvement of PR8-Derived Recombinant Clade 2.3.4.4c H5N6 Vaccine Strains by Optimization of Internal Genes and H103Y Mutation of Hemagglutinin. Vaccines (Basel) 2020;8:781. [PMID: 33419331 DOI: 10.3390/vaccines8040781] [Reference Citation Analysis]
271 Ellwanger JH, Kulmann-Leal B, Kaminski VL, Rodrigues AG, Bragatte MAS, Chies JAB. Beyond HIV infection: Neglected and varied impacts of CCR5 and CCR5Δ32 on viral diseases. Virus Res 2020;286:198040. [PMID: 32479976 DOI: 10.1016/j.virusres.2020.198040] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
272 Lagardère P, Fersing C, Masurier N, Lisowski V. Thienopyrimidine: A Promising Scaffold to Access Anti-Infective Agents. Pharmaceuticals (Basel) 2021;15:35. [PMID: 35056092 DOI: 10.3390/ph15010035] [Reference Citation Analysis]
273 Kovaleva KS, Zubkov FI, Bormotov NI, Novikov RA, Dorovatovskii PV, Khrustalev VN, Gatilov YV, Zarubaev VV, Yarovaya OI, Shishkina LN, Salakhutdinov NF. Synthesis of d-(+)-camphor-based N-acylhydrazones and their antiviral activity. Medchemcomm 2018;9:2072-82. [PMID: 30746065 DOI: 10.1039/c8md00442k] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
274 Terrier O, Slama-Schwok A. Anti-Influenza Drug Discovery and Development: Targeting the Virus and Its Host by All Possible Means. Adv Exp Med Biol 2021;1322:195-218. [PMID: 34258742 DOI: 10.1007/978-981-16-0267-2_8] [Reference Citation Analysis]
275 Palatnick A, Zhou B, Ghedin E, Schatz MC. iGenomics: Comprehensive DNA sequence analysis on your Smartphone. Gigascience 2020;9:giaa138. [PMID: 33284326 DOI: 10.1093/gigascience/giaa138] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
276 Al-Beltagi S, Preda CA, Goulding LV, James J, Pu J, Skinner P, Jiang Z, Wang BL, Yang J, Banyard AC, Mellits KH, Gershkovich P, Hayes CJ, Nguyen-Van-Tam J, Brown IH, Liu J, Chang KC. Thapsigargin Is a Broad-Spectrum Inhibitor of Major Human Respiratory Viruses: Coronavirus, Respiratory Syncytial Virus and Influenza A Virus. Viruses 2021;13:234. [PMID: 33546185 DOI: 10.3390/v13020234] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
277 Trigueiro-Louro JM, Correia V, Santos LA, Guedes RC, Brito RMM, Rebelo-de-Andrade H. To hit or not to hit: Large-scale sequence analysis and structure characterization of influenza A NS1 unlocks new antiviral target potential. Virology 2019;535:297-307. [PMID: 31104825 DOI: 10.1016/j.virol.2019.04.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
278 Mauvais-Jarvis F, Bairey Merz N, Barnes PJ, Brinton RD, Carrero JJ, DeMeo DL, De Vries GJ, Epperson CN, Govindan R, Klein SL, Lonardo A, Maki PM, McCullough LD, Regitz-Zagrosek V, Regensteiner JG, Rubin JB, Sandberg K, Suzuki A. Sex and gender: modifiers of health, disease, and medicine. Lancet 2020;396:565-82. [PMID: 32828189 DOI: 10.1016/S0140-6736(20)31561-0] [Cited by in Crossref: 187] [Cited by in F6Publishing: 109] [Article Influence: 93.5] [Reference Citation Analysis]
279 Seok JH, Kim H, Lee DB, An JS, Kim EJ, Lee JH, Chung MS, Kim KH. Divalent cation-induced conformational changes of influenza virus hemagglutinin. Sci Rep 2020;10:15457. [PMID: 32963316 DOI: 10.1038/s41598-020-72368-x] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
280 Qiu Z, Cao Z, Zou M, Tang K, Zhang C, Tang J, Zeng J, Wang Y, Sun Q, Wang D, Du X. The effectiveness of governmental nonpharmaceutical interventions against COVID-19 at controlling seasonal influenza transmission: an ecological study. BMC Infect Dis 2022;22:331. [PMID: 35379168 DOI: 10.1186/s12879-022-07317-2] [Reference Citation Analysis]
281 Liu Y, Lv J, Liu J, Li M, Xie J, Lv Q, Deng W, Zhou N, Zhou Y, Song J, Wang P, Qin C, Tong WM, Huang B. Mucus production stimulated by IFN-AhR signaling triggers hypoxia of COVID-19. Cell Res 2020;30:1078-87. [PMID: 33159154 DOI: 10.1038/s41422-020-00435-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
282 Lu Y, Landreth S, Gaba A, Hlasny M, Liu G, Huang Y, Zhou Y. In Vivo Characterization of Avian Influenza A (H5N1) and (H7N9) Viruses Isolated from Canadian Travelers. Viruses 2019;11:E193. [PMID: 30813415 DOI: 10.3390/v11020193] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
283 Huang SW, Wang SF. The Effects of Genetic Variation on H7N9 Avian Influenza Virus Pathogenicity. Viruses 2020;12:E1220. [PMID: 33126529 DOI: 10.3390/v12111220] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
284 Hoagland DA, Møller R, Uhl SA, Oishi K, Frere J, Golynker I, Horiuchi S, Panis M, Blanco-Melo D, Sachs D, Arkun K, Lim JK, tenOever BR. Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity. Immunity 2021;54:557-570.e5. [PMID: 33577760 DOI: 10.1016/j.immuni.2021.01.017] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 46.0] [Reference Citation Analysis]
285 Ueno H. Tfh cell response in influenza vaccines in humans: what is visible and what is invisible. Curr Opin Immunol 2019;59:9-14. [PMID: 30921542 DOI: 10.1016/j.coi.2019.02.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
286 Cutillo G, Saariaho AH, Meri S. Physiology of gangliosides and the role of antiganglioside antibodies in human diseases. Cell Mol Immunol 2020;17:313-22. [PMID: 32152553 DOI: 10.1038/s41423-020-0388-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 10.0] [Reference Citation Analysis]
287 Nagy A, Černíková L, Kunteová K, Dirbáková Z, Thomas SS, Slomka MJ, Dán Á, Varga T, Máté M, Jiřincová H, Brown IH. A universal RT-qPCR assay for "One Health" detection of influenza A viruses. PLoS One 2021;16:e0244669. [PMID: 33471840 DOI: 10.1371/journal.pone.0244669] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
288 Chen W, Shao J, Ying Z, Du Y, Yu Y. Approaches for discovery of small-molecular antivirals targeting to influenza A virus PB2 subunit. Drug Discov Today 2022:S1359-6446(22)00085-X. [PMID: 35247593 DOI: 10.1016/j.drudis.2022.02.024] [Reference Citation Analysis]
289 Koutsakos M, Sekiya T, Chua BY, Nguyen THO, Wheatley AK, Juno JA, Ohno M, Nomura N, Ohara Y, Nishimura T, Endo M, Suzuki S, Ishigaki H, Nakayama M, Nguyen CT, Itoh Y, Shingai M, Ogasawara K, Kino Y, Kent SJ, Jackson DC, Brown LE, Kida H, Kedzierska K. Immune profiling of influenza-specific B- and T-cell responses in macaques using flow cytometry-based assays. Immunol Cell Biol 2021;99:97-106. [PMID: 32741011 DOI: 10.1111/imcb.12383] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
290 Han X, Xu P, Wang H, Mao J, Ye Q. Incident changes in the prevalence of respiratory virus among children during COVID-19 pandemic in Hangzhou, China. J Infect 2022:S0163-4453(22)00006-8. [PMID: 35016902 DOI: 10.1016/j.jinf.2022.01.007] [Reference Citation Analysis]
291 Parra-lucares A, Segura P, Rojas V, Pumarino C, Saint-pierre G, Toro L. Emergence of SARS-CoV-2 Variants in the World: How Could This Happen? Life 2022;12:194. [DOI: 10.3390/life12020194] [Reference Citation Analysis]
292 Bansal A, Trieu MC, Mohn KGI, Cox RJ. Safety, Immunogenicity, Efficacy and Effectiveness of Inactivated Influenza Vaccines in Healthy Pregnant Women and Children Under 5 Years: An Evidence-Based Clinical Review. Front Immunol 2021;12:744774. [PMID: 34691051 DOI: 10.3389/fimmu.2021.744774] [Reference Citation Analysis]
293 Hobbs CV, Khaitan A, Kirmse BM, Borkowsky W. COVID-19 in Children: A Review and Parallels to Other Hyperinflammatory Syndromes. Front Pediatr 2020;8:593455. [PMID: 33330288 DOI: 10.3389/fped.2020.593455] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
294 Oh S, Lee MK, Chi SW. Single-Molecule-Based Detection of Conserved Influenza A Virus RNA Promoter Using a Protein Nanopore. ACS Sens 2019;4:2849-53. [PMID: 31689087 DOI: 10.1021/acssensors.9b01558] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
295 Lewandowski K, Xu Y, Pullan ST, Lumley SF, Foster D, Sanderson N, Vaughan A, Morgan M, Bright N, Kavanagh J, Vipond R, Carroll M, Marriott AC, Gooch KE, Andersson M, Jeffery K, Peto TEA, Crook DW, Walker AS, Matthews PC. Metagenomic Nanopore Sequencing of Influenza Virus Direct from Clinical Respiratory Samples. J Clin Microbiol 2019;58:e00963-19. [PMID: 31666364 DOI: 10.1128/JCM.00963-19] [Cited by in Crossref: 52] [Cited by in F6Publishing: 33] [Article Influence: 17.3] [Reference Citation Analysis]
296 Truong PT, Saito S, Takayama I, Furuya H, Nguyen BG, Do TV, Phan PT, Do CD, Dao CX, Pham TT, Dang TQ, Ngo CQ, Le NT, Bui VM, Le DT, Vu VTT, Pham TTP, Arashiro T, Kageyama T, Nakajima N. Respiratory microbes detected in hospitalized adults with acute respiratory infections: associations between influenza A(H1N1)pdm09 virus and intensive care unit admission or fatal outcome in Vietnam (2015-2017). BMC Infect Dis 2021;21:320. [PMID: 33823790 DOI: 10.1186/s12879-021-05988-x] [Reference Citation Analysis]
297 Uribe Soto M, Gómez Ramírez AP, Ramírez Nieto GC. INFLUENZA REQUIERE UN MANEJO BAJO LA PERSPECTIVA DE “ONE HEALTH” EN COLOMBIA. Acta biol Colomb 2020;25:421-30. [DOI: 10.15446/abc.v25n3.79364] [Reference Citation Analysis]
298 Bai Y, Tao X. Comparison of COVID-19 and influenza characteristics. J Zhejiang Univ Sci B 2021;22:87-98. [PMID: 33615750 DOI: 10.1631/jzus.B2000479] [Reference Citation Analysis]
299 Herbstreit F, Overbeck M, Berger MM, Skarabis A, Brenner T, Schmidt K. Characteristics of Critically Ill Patients with COVID-19 Compared to Patients with Influenza-A Single Center Experience. J Clin Med 2021;10:2056. [PMID: 34064851 DOI: 10.3390/jcm10102056] [Reference Citation Analysis]
300 Liu Y, Retout S, Duval V, Jia J, Zou Y, Wang Y, Cosson V, Jolivet S, De Buck S. Pharmacokinetics, safety, and simulated efficacy of an influenza treatment, baloxavir marboxil, in Chinese individuals. Clin Transl Sci 2022. [PMID: 35176206 DOI: 10.1111/cts.13237] [Reference Citation Analysis]
301 Ilyicheva T, Marchenko V, Pyankova O, Moiseeva A, Nhai TT, Lan Anh BT, Sau TK, Kuznetsov A, Ryzhikov A, Maksyutov R. Antibodies to Highly Pathogenic A/H5Nx (Clade 2.3.4.4) Influenza Viruses in the Sera of Vietnamese Residents. Pathogens 2021;10:394. [PMID: 33806156 DOI: 10.3390/pathogens10040394] [Reference Citation Analysis]
302 Skelton RM, Huber VC. Comparing Influenza Virus Biology for Understanding Influenza D Virus. Viruses 2022;14:1036. [DOI: 10.3390/v14051036] [Reference Citation Analysis]
303 Strohmeier S, Carreño JM, Brito RN, Krammer F. Introduction of Cysteines in the Stalk Domain of Recombinant Influenza Virus N1 Neuraminidase Enhances Protein Stability and Immunogenicity in Mice. Vaccines (Basel) 2021;9:404. [PMID: 33921722 DOI: 10.3390/vaccines9040404] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
304 Esposito S, Nauta J, Lapini G, Montomoli E, van de Witte S. Efficacy and safety of a quadrivalent influenza vaccine in children aged 6–35 months: A global, multiseasonal, controlled, randomized Phase III study. Vaccine 2022. [DOI: 10.1016/j.vaccine.2022.02.088] [Reference Citation Analysis]
305 Ashraf U, Tengo L, Le Corre L, Fournier G, Busca P, McCarthy AA, Rameix-Welti MA, Gravier-Pelletier C, Ruigrok RWH, Jacob Y, Vidalain PO, Pietrancosta N, Crépin T, Naffakh N. Destabilization of the human RED-SMU1 splicing complex as a basis for host-directed antiinfluenza strategy. Proc Natl Acad Sci U S A 2019;116:10968-77. [PMID: 31076555 DOI: 10.1073/pnas.1901214116] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
306 Weil-Olivier C, Taha MK, Bouée S, Emery C, Loncle-Provot V, Nachbaur G, Beck E, Pribil C. Care pathways in invasive meningococcal disease: a retrospective analysis of the French national public health insurance database. Hum Vaccin Immunother 2022;:1-11. [PMID: 35192785 DOI: 10.1080/21645515.2021.2021764] [Reference Citation Analysis]
307 Ursin RL, Liu H, Powell HR, Westerbeck JW, Shaw-Saliba K, Sylvia KE, Fenstermacher KJ, Mehoke T, Thielen P, Rothman RE, Pekosz A, Klein SL. Differential Antibody Recognition of H3N2 Vaccine and Seasonal Influenza Virus Strains Based on Age, Vaccine Status, and Sex in the 2017-2018 Season. J Infect Dis 2020;222:1371-82. [PMID: 32496543 DOI: 10.1093/infdis/jiaa289] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
308 Staller E, Barclay WS. Host Cell Factors That Interact with Influenza Virus Ribonucleoproteins. Cold Spring Harb Perspect Med 2021;11:a038307. [PMID: 32988980 DOI: 10.1101/cshperspect.a038307] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
309 Zhou Z, Li B, Liu X, Li Z, Zhu S, Liang Y, Cui Z, Wu S. Recent Progress in Photocatalytic Antibacterial. ACS Appl Bio Mater 2021;4:3909-36. [DOI: 10.1021/acsabm.0c01335] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
310 Overeem NJ, van der Vries E, Huskens J. A Dynamic, Supramolecular View on the Multivalent Interaction between Influenza Virus and Host Cell. Small 2021;17:e2007214. [PMID: 33682339 DOI: 10.1002/smll.202007214] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
311 Li Y, He H, Gao Y, Ou Z, He W, Chen C, Fu J, Xiong H, Chen Q. Comparison of Clinical Characteristics for Distinguishing COVID-19 From Influenza During the Early Stages in Guangdong, China. Front Med (Lausanne) 2021;8:733999. [PMID: 34859002 DOI: 10.3389/fmed.2021.733999] [Reference Citation Analysis]
312 Jang Y, Seo SH. H5 cleavage-site peptide vaccine protects chickens from lethal infection by highly pathogenic H5 avian influenza viruses. Arch Virol 2021. [PMID: 34693488 DOI: 10.1007/s00705-021-05284-8] [Reference Citation Analysis]
313 Gaur P, Kumar P, Sharma A, Lal SK. AML1 protein interacts with influenza A virus neuraminidase and upregulates IFN-β response in infected mammalian cells. Lett Appl Microbiol 2020;70:252-8. [PMID: 31990997 DOI: 10.1111/lam.13279] [Reference Citation Analysis]
314 Banti C, Kourkoumelis N, Hatzidimitriou A, Antoniadou I, Dimou A, Rallis M, Hoffmann A, Schmidtke M, Mcguire K, Busath D, Kolocouris A, Hadjikakou S. Amantadine copper(II) chloride conjugate with possible implementation in influenza virus inhibition. Polyhedron 2020;185:114590. [DOI: 10.1016/j.poly.2020.114590] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
315 Mishra R, Banerjea AC. Neurological Damage by Coronaviruses: A Catastrophe in the Queue! Front Immunol 2020;11:565521. [PMID: 33013930 DOI: 10.3389/fimmu.2020.565521] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
316 Meng X, Zhao H, Ou R, Zeng Q, Lv H, Zhu H, Ye M. Epidemiological and Clinical Characteristics of Influenza Outbreaks Among Children in Chongqing, China. Front Public Health 2022;10:760746. [DOI: 10.3389/fpubh.2022.760746] [Reference Citation Analysis]
317 Groaz E, De Clercq E, Herdewijn P. Anno 2021: Which antivirals for the coming decade? Annu Rep Med Chem 2021;57:49-107. [PMID: 34744210 DOI: 10.1016/bs.armc.2021.09.004] [Reference Citation Analysis]
318 Cai C, Xu L, Fang J, Dai Z, Wu Q, Liu X, Wang Q, Fang J, Liu AL, Du GH. In Silico Prediction and Bioactivity Evaluation of Chemical Ingredients Against Influenza A Virus From Isatis tinctoria L. Front Pharmacol 2021;12:755396. [PMID: 34950027 DOI: 10.3389/fphar.2021.755396] [Reference Citation Analysis]
319 Huang MT, Zhang S, Wu YN, Li W, Li YC, Zhou CS, Kang XP, Jiang T. Dual R108K and G189D Mutations in the NS1 Protein of A/H1N1 Influenza Virus Counteract Host Innate Immune Responses. Viruses 2021;13:905. [PMID: 34068322 DOI: 10.3390/v13050905] [Reference Citation Analysis]
320 Ko YA, Yu YH, Wu YF, Tseng YC, Chen CL, Goh KS, Liao HY, Chen TH, Cheng TR, Yang AS, Wong CH, Ma C, Lin KI. A non-neutralizing antibody broadly protects against influenza virus infection by engaging effector cells. PLoS Pathog 2021;17:e1009724. [PMID: 34352041 DOI: 10.1371/journal.ppat.1009724] [Reference Citation Analysis]
321 Hao W, Wang L, Li S. Roles of the Non-Structural Proteins of Influenza A Virus. Pathogens 2020;9:E812. [PMID: 33023047 DOI: 10.3390/pathogens9100812] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
322 Tran V, Ledwith MP, Thamamongood T, Higgins CA, Tripathi S, Chang MW, Benner C, García-Sastre A, Schwemmle M, Boon ACM, Diamond MS, Mehle A. Influenza virus repurposes the antiviral protein IFIT2 to promote translation of viral mRNAs. Nat Microbiol 2020;5:1490-503. [PMID: 32839537 DOI: 10.1038/s41564-020-0778-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
323 Verhagen JH, Fouchier RAM, Lewis N. Highly Pathogenic Avian Influenza Viruses at the Wild-Domestic Bird Interface in Europe: Future Directions for Research and Surveillance. Viruses 2021;13:212. [PMID: 33573231 DOI: 10.3390/v13020212] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
324 Soudani S, Mafi A, Al Mayahi Z, Al Balushi S, Dbaibo G, Al Awaidy S, Amiche A. A Systematic Review of Influenza Epidemiology and Surveillance in the Eastern Mediterranean and North African Region. Infect Dis Ther 2022. [PMID: 34997913 DOI: 10.1007/s40121-021-00534-3] [Reference Citation Analysis]
325 Tarn WY, Cheng Y, Ko SH, Huang LM. Antisense Oligonucleotide-Based Therapy of Viral Infections. Pharmaceutics 2021;13:2015. [PMID: 34959297 DOI: 10.3390/pharmaceutics13122015] [Reference Citation Analysis]
326 Furukawa H, Inaba H, Sasaki Y, Akiyoshi K, Matsuura K. Embedding a membrane protein into an enveloped artificial viral replica. RSC Chem Biol . [DOI: 10.1039/d1cb00166c] [Reference Citation Analysis]
327 Zanaty AM, Erfan AM, Mady WH, Amer F, Nour AA, Rabie N, Samy M, Selim AA, Hassan WMM, Naguib MM. Avian influenza virus surveillance in migratory birds in Egypt revealed a novel reassortant H6N2 subtype. Avian Res 2019;10. [DOI: 10.1186/s40657-019-0180-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
328 Zhou A, Dong X, Liu M, Tang B. Comprehensive Transcriptomic Analysis Identifies Novel Antiviral Factors Against Influenza A Virus Infection. Front Immunol 2021;12:632798. [PMID: 34367124 DOI: 10.3389/fimmu.2021.632798] [Reference Citation Analysis]
329 Pecetta S, Finco O, Seubert A. Quantum leap of monoclonal antibody (mAb) discovery and development in the COVID-19 era. Semin Immunol 2020;50:101427. [PMID: 33277154 DOI: 10.1016/j.smim.2020.101427] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
330 Zaraket H, Hurt AC, Clinch B, Barr I, Lee N. Burden of influenza B virus infection and considerations for clinical management. Antiviral Res 2021;185:104970. [PMID: 33159999 DOI: 10.1016/j.antiviral.2020.104970] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
331 Veerapandian R, Snyder JD, Samarasinghe AE. Influenza in Asthmatics: For Better or for Worse? Front Immunol 2018;9:1843. [PMID: 30147697 DOI: 10.3389/fimmu.2018.01843] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
332 Lim K, Kodera N, Wang H, Mohamed MS, Hazawa M, Kobayashi A, Yoshida T, Hanayama R, Yano S, Ando T, Wong RW. High-Speed AFM Reveals Molecular Dynamics of Human Influenza A Hemagglutinin and Its Interaction with Exosomes. Nano Lett 2020;20:6320-8. [DOI: 10.1021/acs.nanolett.0c01755] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
333 B Carvalho S, Peixoto C, T Carrondo MJ, S Silva RJ. Downstream processing for influenza vaccines and candidates: An update. Biotechnol Bioeng 2021;118:2845-69. [PMID: 33913510 DOI: 10.1002/bit.27803] [Reference Citation Analysis]
334 Yegani S, Shoushtari AH, Eshratabadi F, Molouki A. Full sequence analysis of hemagglutinin and neuraminidase genes and proteins of highly pathogenic avian influenza H5N1 virus detected in Iran, 2015. Trop Anim Health Prod 2019;51:605-12. [PMID: 30368763 DOI: 10.1007/s11250-018-1731-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
335 Minh Le T, Szakonyi Z. Enantiomeric Isopulegol as the Chiral Pool in the Total Synthesis of Bioactive Agents. Chem Rec 2021. [PMID: 34553822 DOI: 10.1002/tcr.202100194] [Reference Citation Analysis]
336 Mahal A, Duan M, Zinad DS, Mohapatra RK, Obaidullah AJ, Wei X, Pradhan MK, Das D, Kandi V, Zinad HS, Zhu Q. Recent progress in chemical approaches for the development of novel neuraminidase inhibitors. RSC Adv 2021;11:1804-40. [DOI: 10.1039/d0ra07283d] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
337 Zheng J, Wen L, Yen HL, Liu M, Liu Y, Teng O, Wu WF, Ni K, Lam KT, Huang C, Yang J, Lau YL, Perlman S, Peiris M, Tu W. Phenotypic and Functional Characteristics of a Novel Influenza Virus Hemagglutinin-Specific Memory NK Cell. J Virol 2021;95:e00165-21. [PMID: 33827945 DOI: 10.1128/JVI.00165-21] [Reference Citation Analysis]
338 Szymański K, Hallmann E, Łuniewska K, Kondratiuk K, Poznańska A, Brydak LB. Spread of Influenza Viruses in Poland and Neighboring Countries in Seasonal Terms. Pathogens 2021;10:316. [PMID: 33800306 DOI: 10.3390/pathogens10030316] [Reference Citation Analysis]
339 Rivera-Patron M, Moreno M, Baz M, Roehe PM, Cibulski SP, Silveira F. ISCOM-like Nanoparticles Formulated with Quillaja brasiliensis Saponins Are Promising Adjuvants for Seasonal Influenza Vaccines. Vaccines (Basel) 2021;9:1350. [PMID: 34835281 DOI: 10.3390/vaccines9111350] [Reference Citation Analysis]
340 Thompson AJ, Cao L, Ma Y, Wang X, Diedrich JK, Kikuchi C, Willis S, Worth C, McBride R, Yates JR 3rd, Paulson JC. Human Influenza Virus Hemagglutinins Contain Conserved Oligomannose N-Linked Glycans Allowing Potent Neutralization by Lectins. Cell Host Microbe 2020;27:725-735.e5. [PMID: 32298658 DOI: 10.1016/j.chom.2020.03.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
341 Demchenko V, Kobylinskyi S, Iurzhenko M, Riabov S, Vashchuk A, Rybalchenko N, Zahorodnia S, Naumenko K, Demchenko O, Adamus G, Kowalczuk M. Nanocomposites based on polylactide and silver nanoparticles and their antimicrobial and antiviral applications. Reactive and Functional Polymers 2022;170:105096. [DOI: 10.1016/j.reactfunctpolym.2021.105096] [Reference Citation Analysis]
342 Santos NB, Vaz da Silva ZE, Gomes C, Reis CA, Amorim MJ. Complement Decay-Accelerating Factor is a modulator of influenza A virus lung immunopathology. PLoS Pathog 2021;17:e1009381. [PMID: 34197564 DOI: 10.1371/journal.ppat.1009381] [Reference Citation Analysis]
343 Zhang Q, Mei X, Zhang C, Li J, Chang N, Aji D, Shi W, Bi Y, Ma Z. Novel reassortant 2.3.4.4B H5N6 highly pathogenic avian influenza viruses circulating among wild, domestic birds in Xinjiang, Northwest China. J Vet Sci 2021;22:e43. [PMID: 34170087 DOI: 10.4142/jvs.2021.22.e43] [Reference Citation Analysis]
344 De Marco MA, Delogu M, Facchini M, Di Trani L, Boni A, Cotti C, Graziosi G, Venturini D, Regazzi D, Ravaioli V, Marzadori F, Frasnelli M, Castrucci MR, Raffini E. Serologic Evidence of Occupational Exposure to Avian Influenza Viruses at the Wildfowl/Poultry/Human Interface. Microorganisms 2021;9:2153. [PMID: 34683475 DOI: 10.3390/microorganisms9102153] [Reference Citation Analysis]
345 Amer F, Li R, Rabie N, El-Husseiny MH, Yehia N, Hagag NM, Samy M, Selim A, Hassan MK, Hassan WMM, Arafa AS, Lundkvist Å, Shahein MA, Naguib MM. Temporal Dynamics of Influenza A(H5N1) Subtype before and after the Emergence of H5N8. Viruses 2021;13:1565. [PMID: 34452430 DOI: 10.3390/v13081565] [Reference Citation Analysis]
346 Peukert K, Seeliger B, Fox M, Feuerborn C, Sauer A, Schuss P, Schneider M, David S, Welte T, Putensen C, Wilhelm C, Steinhagen F, Bode C. SP-D Serum Levels Reveal Distinct Epithelial Damage in Direct Human ARDS. J Clin Med 2021;10:737. [PMID: 33673270 DOI: 10.3390/jcm10040737] [Reference Citation Analysis]